<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>KCTD4 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>KCTD4</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q8WVF5" target="_blank" class="term-link">
                        Q8WVF5
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "KCTD4";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q8WVF5" data-a="DESCRIPTION: KCTD4 encodes a BTB/POZ domain-containing protein ..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>KCTD4 encodes a BTB/POZ domain-containing protein belonging to the potassium channel tetramerization domain (KCTD) family. The protein contains an N-terminal BTB/T1 (T1-type BTB) domain that mediates oligomerization, predicted to form pentameric assemblies. Unlike some KCTD family members, KCTD4 is not predicted to form stable complexes with Cullin 3 (Cul3) based on AlphaFold modeling, and is not part of the GABAB receptor-associated KCTD subclade (KCTD8/12/16). KCTD4 can form hetero-oligomeric complexes with other KCTD family members such as KCTD5. The protein is expressed in brain tissue and its precise molecular function remains to be fully characterized experimentally. Limited KCTD4-specific mechanistic literature exists, with function largely inferred from family-level analyses.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042802" target="_blank" class="term-link">
                                    GO:0042802
                                </a>
                            </span>
                            <span class="term-label">identical protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000117
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8WVF5" data-a="GO:0042802" data-r="GO_REF:0000117" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD4 contains a BTB/T1 domain that mediates homo-oligomerization, a conserved feature of the KCTD family. Structural predictions indicate KCTD4 forms pentameric assemblies. The BTB domain is well-documented to drive self-association in KCTD proteins (KCTD4-deep-research-falcon.md).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The identical protein binding annotation is well-supported by structural and family-level evidence. KCTD proteins characteristically oligomerize via their N-terminal BTB/T1 domain. AlphaFold-based structural clustering places KCTD4 in a pentameric cluster (Balasco et al. 2024). Family reviews confirm that KCTDs are intracellular proteins whose N-terminal BTB/T1 domain is structurally related to BTB/POZ folds and adapted to drive homo-oligomerization (Teng et al. 2019).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD4/KCTD4-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Structural clustering (AlphaFold/analysis) groups KCTD4 in a pentameric cluster (Cluster 4).</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD4/KCTD4-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">KCTDs are intracellular proteins whose N-terminal BTB/T1 domain is structurally related to BTB/POZ folds and adapted to drive homo-oligomerization.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051260" target="_blank" class="term-link">
                                    GO:0051260
                                </a>
                            </span>
                            <span class="term-label">protein homooligomerization</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8WVF5" data-a="GO:0051260" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> KCTD4 is predicted to form pentameric homooligomers via its BTB/T1 domain, consistent with the structural architecture of other KCTD family members (KCTD4-deep-research-falcon.md).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The protein homooligomerization annotation is supported by structural predictions and family-level evidence. AlphaFold-based analysis specifically assigns KCTD4 to a pentameric assembly cluster (Balasco et al. 2024). The InterPro2GO mapping is appropriate given the T1-type BTB domain (IPR003131) present in KCTD4, which is known to mediate oligomerization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/KCTD4/KCTD4-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Assigned/predicted pentameric assembly for KCTD4. Structural clustering (AlphaFold/analysis) groups KCTD4 in a pentameric cluster (Cluster 4).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/25910212" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:25910212
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Widespread macromolecular interaction perturbations in human...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q8WVF5" data-a="GO:0005515" data-r="PMID:25910212" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation derives from a large-scale interactome study examining how disease-associated mutations affect protein-protein interactions. The study was not focused on characterizing KCTD4 function specifically.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Per GO curation guidelines, the term &#34;protein binding&#34; (GO:0005515) is uninformative and should be avoided. This annotation comes from a high-throughput Y2H screen studying disease mutation effects on protein interactions (Sahni et al. 2015). While the interaction data may be valid, the generic &#34;protein binding&#34; annotation provides no insight into KCTD4&#39;s actual molecular function. More specific molecular function terms should be used when available.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/25910212" target="_blank" class="term-link">
                                        PMID:25910212
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Here we functionally profile several thousand missense mutations across a spectrum of Mendelian disorders using various interaction assays.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/27107014" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:27107014
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    An inter-species protein-protein interaction network across ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q8WVF5" data-a="GO:0005515" data-r="PMID:27107014" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation derives from a yeast-human inter-species interactome mapping study examining evolutionary conservation of protein interactions. KCTD4 was detected in high-throughput screens but not specifically characterized.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Per GO curation guidelines, the term &#34;protein binding&#34; (GO:0005515) is uninformative and should be avoided. This annotation comes from an inter-species interactome mapping study (Zhong et al. 2016) examining yeast-human protein interactions across evolutionary distance. While the detection of KCTD4 in interaction screens may be valid, the generic &#34;protein binding&#34; term provides no functional insight. The interaction could reflect the BTB domain&#39;s oligomerization properties rather than a specific functional interaction.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/27107014" target="_blank" class="term-link">
                                        PMID:27107014
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We systematically probed the yeast and human proteomes for interactions between proteins from these two species and functionally characterized the resulting inter-interactome network.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296183
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A reference map of the human binary protein interactome.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q8WVF5" data-a="GO:0005515" data-r="PMID:32296183" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation derives from the HuRI (Human Reference Interactome) project, a systematic all-by-all binary protein interaction screen. KCTD4 was detected as having protein interactions but without specific functional characterization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Per GO curation guidelines, the term &#34;protein binding&#34; (GO:0005515) is uninformative and should be avoided. This annotation comes from the HuRI project (Luck et al. 2020), a systematic reference interactome map. While HuRI provides high-quality binary interaction data, the generic &#34;protein binding&#34; annotation does not convey specific molecular function information. UniProt lists specific interactions with DAXX, EFHC1, and NTAQ1 (from IntAct), but the functional significance of these interactions for KCTD4 remains unclear.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                                        PMID:32296183
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Here we present a human &#39;all-by-all&#39; reference interactome map of human binary protein interactions, or &#39;HuRI&#39;. With approximately 53,000 protein-protein interactions, HuRI has approximately four times as many such interactions as there are high-quality curated interactions from small-scale studies.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>KCTD4 contains a BTB/T1 domain that is well-documented to mediate homo-oligomerization in the KCTD protein family. Structural predictions using AlphaFold place KCTD4 in a pentameric assembly cluster.</h3>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="FUNCTION: KCTD4 contains a BTB/T1 domain that is well-docume..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042802" target="_blank" class="term-link">
                            identical protein binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0051260" target="_blank" class="term-link">
                                protein homooligomerization
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD4 contains BTB_2 domain (PF02214) which is associated with protein oligomerization</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000117.md" target="_blank" class="term-link">
                            GO_REF:0000117
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Electronic Gene Ontology annotations created by ARBA machine learning models</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Prediction of identical protein binding based on sequence features</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25910212" target="_blank" class="term-link">
                            PMID:25910212
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Widespread macromolecular interaction perturbations in human genetic disorders.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">High-throughput Y2H screen examining disease mutation effects on PPIs</div>
                        
                        <div class="finding-text">"Here we functionally profile several thousand missense mutations across a spectrum of Mendelian disorders using various interaction assays."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD4 detected in interaction assays but not a focus of study</div>
                        
                        <div class="finding-text">"Approximately 60% of disease-associated missense mutations perturb PPIs"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27107014" target="_blank" class="term-link">
                            PMID:27107014
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">An inter-species protein-protein interaction network across vast evolutionary distance.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Yeast-human inter-interactome mapping study</div>
                        
                        <div class="finding-text">"We systematically probed the yeast and human proteomes for interactions between proteins from these two species"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD4 detected in screens but not specifically characterized</div>
                        
                        <div class="finding-text">"we identified 1,583 inter-species interactions between 566 yeast and 471 human proteins"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                            PMID:32296183
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A reference map of the human binary protein interactome.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">HuRI project providing systematic binary PPI reference map</div>
                        
                        <div class="finding-text">"Here we present a human &#39;all-by-all&#39; reference interactome map of human binary protein interactions, or &#39;HuRI&#39;."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD4 detected in systematic Y2H screens</div>
                        
                        <div class="finding-text">"With approximately 53,000 protein-protein interactions, HuRI has approximately four times as many such interactions as there are high-quality curated interactions from small-scale studies."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/KCTD4/KCTD4-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research review of KCTD4 function</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD4 predicted to form pentameric assembly</div>
                        
                        <div class="finding-text">"Structural clustering (AlphaFold/analysis) groups KCTD4 in a pentameric cluster (Cluster 4)."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD4 unlikely to form stable Cul3 complex</div>
                        
                        <div class="finding-text">"KCTD4 predicted NOT to form a stable Cul3 complex (AlphaFold models gave a &#39;meaningless complex&#39; / poor PAE)."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">BTB/T1 domain mediates homo-oligomerization</div>
                        
                        <div class="finding-text">"KCTDs are intracellular proteins whose N-terminal BTB/T1 domain is structurally related to BTB/POZ folds and adapted to drive homo-oligomerization"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">KCTD4 can hetero-oligomerize with KCTD5</div>
                        
                        <div class="finding-text">"Experimental cell-based interaction assays (co-IP, BRET) demonstrate KCTD5 hetero-oligomerization across family members, including KCTD4 as a detected partner."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does KCTD4 interact with Gbetagamma subunits of heterotrimeric G proteins, as demonstrated for other KCTD family members (KCTD2/5/17)?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="Q: Does KCTD4 interact with Gbetagamma subunits of he..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the functional significance of KCTD4 hetero-oligomerization with KCTD5?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="Q: What is the functional significance of KCTD4 heter..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does KCTD4 have any role in ubiquitin-proteasome pathways despite predicted lack of stable Cul3 binding?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="Q: Does KCTD4 have any role in ubiquitin-proteasome p..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the subcellular localization of KCTD4 in brain tissue where it is preferentially expressed?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="Q: What is the subcellular localization of KCTD4 in b..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Biochemical characterization of KCTD4-Cul3 interaction using co-IP and in vitro reconstitution to confirm or refute AlphaFold predictions</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: KCTD4 does not form stable complexes with Cul3, unlike some other KCTD family members</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="EXPERIMENT: Biochemical characterization of KCTD4-Cul3 interac..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Direct binding assays (BRET, co-IP) to test KCTD4-Gbetagamma interaction</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: KCTD4 may bind Gbetagamma subunits similar to KCTD2/5/17 family members</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="EXPERIMENT: Direct binding assays (BRET, co-IP) to test KCTD4-..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Subcellular localization studies in neurons to determine where KCTD4 functions</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: KCTD4 localizes to specific neuronal compartments consistent with its brain-enriched expression</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="EXPERIMENT: Subcellular localization studies in neurons to det..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Interactome mapping to identify specific binding partners beyond generic protein binding annotations</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: KCTD4 has specific functional interaction partners that inform its molecular function</em></p>
                    
                    
                </div>
                <span class="vote-buttons" data-g="Q8WVF5" data-a="EXPERIMENT: Interactome mapping to identify specific binding p..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(KCTD4-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8WVF5" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-27T10:39:14.978873'<br />
end_time: '2025-12-27T10:49:09.371865'<br />
duration_seconds: 594.39<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: KCTD4<br />
  gene_symbol: KCTD4<br />
  uniprot_accession: Q8WVF5<br />
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD4;'<br />
  gene_info: Name=KCTD4;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: BTB/POZ_dom. (IPR000210); KCTD4_C. (IPR045740); SKP1/BTB/POZ_sf.<br />
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 19</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8WVF5</li>
<li><strong>Protein Description:</strong> RecName: Full=BTB/POZ domain-containing protein KCTD4;</li>
<li><strong>Gene Information:</strong> Name=KCTD4;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> BTB/POZ_dom. (IPR000210); KCTD4_C. (IPR045740); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "KCTD4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'KCTD4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>KCTD4</strong> (gene ID: KCTD4, UniProt: Q8WVF5) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8WVF5</li>
<li><strong>Protein Description:</strong> RecName: Full=BTB/POZ domain-containing protein KCTD4;</li>
<li><strong>Gene Information:</strong> Name=KCTD4;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> BTB/POZ_dom. (IPR000210); KCTD4_C. (IPR045740); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "KCTD4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'KCTD4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>KCTD4</strong> (gene ID: KCTD4, UniProt: Q8WVF5) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Comprehensive research report: Human KCTD4 (UniProt: Q8WVF5)</p>
<p>Executive verification and scope<br />
- Gene/protein identity: KCTD4 unequivocally refers to the human BTB/POZ (T1-type) domain-containing protein ‚ÄúBTB/POZ domain-containing protein KCTD4‚Äù (UniProt Q8WVF5). Family-level analyses place KCTD4 within the potassium channel tetramerization domain (KCTD) protein family bearing an N‚Äëterminal BTB/T1 domain (a BTB/POZ fold) (teng2019kctdanew pages 4-7, sokolina2014humangpcrinteractome pages 53-56).<br />
- Organism: Homo sapiens (Human) confirmed (family and domain context; UniProt accession cited above) (teng2019kctdanew pages 4-7, sokolina2014humangpcrinteractome pages 53-56).<br />
- Domain/family alignment: KCTD proteins share an N‚Äëterminal BTB/T1 domain adapted for oligomerization; this matches the provided UniProt domain set (BTB/POZ/T1) (teng2019kctdanew pages 4-7, sokolina2014humangpcrinteractome pages 53-56).<br />
- Ambiguity check: Searches did not reveal conflicting human gene symbols overlapping with non-human KCTD4 entries; evidence indicates limited KCTD4-specific literature relative to other KCTDs, so we prioritize recent KCTD family studies with explicit KCTD4 mentions (sokolina2014humangpcrinteractome pages 53-56, liao2023kctd5formsheterooligomeric pages 9-10, balasco2024acomprehensiveanalysis pages 8-9).</p>
<p>Key concepts and definitions<br />
- KCTD family and BTB/T1 domain: KCTDs are intracellular proteins whose N‚Äëterminal BTB/T1 domain is structurally related to BTB/POZ folds and adapted to drive homo-oligomerization; many KCTDs act as substrate adaptors for Cullin3 (Cul3)-RING E3 ligases, though Cul3 binding is member-specific (teng2019kctdanew pages 4-7, david2018gababreceptorassociatedkctd pages 14-17, sokolina2014humangpcrinteractome pages 53-56). The GABAB-associated KCTD subclade is restricted to KCTD8/12/16 and mediates receptor kinetics via direct receptor tail and G protein interactions; KCTD4 is not part of this subclade (david2018gababreceptorassociatedkctd pages 14-17, teng2019kctdanew pages 4-7).<br />
- Functional paradigms in the family: Two dominant mechanistic themes are (i) CRL3 (Cul3-based) ubiquitin ligase adaptor functions mediated by BTB or alternative motifs, and (ii) modulation of GPCR signaling either as GABAB auxiliary subunits (KCTD8/12/16) or via interactions with GŒ≤Œ≥ affecting cAMP signaling (shown for several KCTDs) (teng2019kctdanew pages 4-7, david2018gababreceptorassociatedkctd pages 14-17, sloan2023multiplepotassiumchannel pages 7-10).</p>
<table>
<thead>
<tr>
<th>Aspect</th>
<th>Finding (concise)</th>
<th style="text-align: right;">Evidence type</th>
<th style="text-align: right;">Year</th>
<th>Key details / statistics</th>
<th>Source (DOI/URL if available)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Identity verification (human, BTB/POZ)</td>
<td>KCTD4 corresponds to human UniProt Q8WVF5; member of KCTD/BTB family (BTB/T1 domain present).</td>
<td style="text-align: right;">Review/annotation</td>
<td style="text-align: right;">2019, 2014</td>
<td>Family-level annotation places KCTD4 in KCTD family with N-terminal BTB/T1 motif typical of KCTDs (family roles summarized).</td>
<td>(teng2019kctdanew pages 4-7, sokolina2014humangpcrinteractome pages 53-56)</td>
</tr>
<tr>
<td>Domain architecture</td>
<td>N-terminal BTB/T1 (BTB/POZ) domain plus variable C-terminal region; C-terminal domains often divergent across family.</td>
<td style="text-align: right;">Review / structural analysis</td>
<td style="text-align: right;">2019, 2024</td>
<td>C-terminal domains vary; BTB mediates oligomerization and can mediate protein interactions in other KCTDs.</td>
<td>(teng2019kctdanew pages 4-7, balasco2024acomprehensiveanalysis pages 8-9) https://doi.org/10.3390/ijms25031881 (balasco2024acomprehensiveanalysis pages 8-9)</td>
</tr>
<tr>
<td>Oligomeric state</td>
<td>Assigned/predicted pentameric assembly for KCTD4.</td>
<td style="text-align: right;">In silico / structural clustering</td>
<td style="text-align: right;">2024</td>
<td>Structural clustering (AlphaFold/analysis) groups KCTD4 in a pentameric cluster (Cluster 4).</td>
<td>(balasco2024acomprehensiveanalysis pages 8-9) https://doi.org/10.3390/ijms25031881</td>
</tr>
<tr>
<td>Predicted/observed Cullin‚Äë3 (Cul3) binding</td>
<td>KCTD4 predicted NOT to form a stable Cul3 complex (AlphaFold models gave a 'meaningless complex' / poor PAE). Family members variably bind Cul3.</td>
<td style="text-align: right;">In silico (prediction) + family-level review</td>
<td style="text-align: right;">2024, 2019</td>
<td>AF-based modeling failed to produce reliable KCTD4‚ÄìCul3 complex; many other KCTDs are Cul3 adaptors but binding is KCTD-specific.</td>
<td>(balasco2024acomprehensiveanalysis pages 8-9, teng2019kctdanew pages 4-7) https://doi.org/10.3390/ijms25031881 (balasco2024acomprehensiveanalysis pages 8-9)</td>
</tr>
<tr>
<td>GABAB-subclade membership</td>
<td>KCTD4 is NOT among the established GABAB-associated KCTDs (those are KCTD8/12/16 subclade).</td>
<td style="text-align: right;">Review / family analysis</td>
<td style="text-align: right;">2018‚Äì2019</td>
<td>GABAB auxiliary subunits are a restricted subclade (KCTD8/12/16); literature does not place KCTD4 in this group.</td>
<td>(david2018gababreceptorassociatedkctd pages 14-17, teng2019kctdanew pages 4-7)</td>
</tr>
<tr>
<td>Interactions with GŒ≤Œ≥ (functional assays)</td>
<td>No direct experimental evidence that KCTD4 binds GŒ≤Œ≥; several other KCTDs (e.g., KCTD2/5/17) do bind GŒ≤Œ≥ and affect cAMP signaling.</td>
<td style="text-align: right;">Primary (family-level assays) / negative for KCTD4</td>
<td style="text-align: right;">2023</td>
<td>Functional IP/BRET and cellular assays show GŒ≤Œ≥ binding for multiple KCTDs; no published KCTD4-specific GŒ≤Œ≥ binding reported in surveyed sources.</td>
<td>(sloan2023multiplepotassiumchannel pages 7-10, sokolina2014humangpcrinteractome pages 53-56) https://doi.org/10.1016/j.jbc.2023.102924 (sloan2023multiplepotassiumchannel pages 7-10)</td>
</tr>
<tr>
<td>Hetero-oligomerization (family context)</td>
<td>KCTD5 can form hetero-oligomeric complexes with various KCTDs, reported to include interactions with KCTD4 in co‚ÄëIP / BRET assays.</td>
<td style="text-align: right;">Primary (co‚ÄëIP, BRET)</td>
<td style="text-align: right;">2023</td>
<td>Experimental cell-based interaction assays (co-IP, BRET) demonstrate KCTD5 hetero-oligomerization across family members, including KCTD4 as a detected partner.</td>
<td>(liao2023kctd5formsheterooligomeric pages 9-10) https://doi.org/10.3390/ijms241814317 (liao2023kctd5formsheterooligomeric pages 9-10)</td>
</tr>
<tr>
<td>Subcellular localization</td>
<td>KCTD family proteins are intracellular/cytosolic; no robust KCTD4-specific localization experimental data found in surveyed sources.</td>
<td style="text-align: right;">Review / family annotation</td>
<td style="text-align: right;">2014, 2018</td>
<td>Family-level descriptions describe KCTDs as soluble intracellular proteins; KCTD4-specific localization not reported in available texts.</td>
<td>(sokolina2014humangpcrinteractome pages 53-56, david2018gababreceptorassociatedkctd pages 14-17)</td>
</tr>
<tr>
<td>Expression evidence (HLA‚ÄëI peptidome / proteomics)</td>
<td>KCTD4-derived peptide(s) observed in an HLA class I peptidome from a hepatocellular carcinoma cell line (proteomics detection).</td>
<td style="text-align: right;">Primary proteomics</td>
<td style="text-align: right;">2007</td>
<td>KCTD4 (Q8WVF5) peptides were detected in an HLA‚ÄëI immunopeptidome dataset (listed among detected proteins/peptides).</td>
<td>(alvarez2007analysisofthe pages 7-9) https://doi.org/10.1002/prca.200600388 (alvarez2007analysisofthe pages 7-9)</td>
</tr>
<tr>
<td>Pathway involvement (GPCR / CRL3 context, family level)</td>
<td>KCTD family implicated in GPCR modulation (GABAB, GŒ≤Œ≥ regulation) and as potential Cul3 adaptors (CRL3); KCTD4 function in these pathways is unconfirmed.</td>
<td style="text-align: right;">Reviews / primary family studies</td>
<td style="text-align: right;">2018‚Äì2019, 2023</td>
<td>Family-level mechanistic data: some KCTDs act as CRL3 substrate adapters and/or GABAB auxiliary subunits; applicability to KCTD4 must be determined experimentally.</td>
<td>(david2018gababreceptorassociatedkctd pages 14-17, teng2019kctdanew pages 4-7, sloan2023multiplepotassiumchannel pages 7-10)</td>
</tr>
<tr>
<td>Disease associations (KCTD4-specific vs family-level)</td>
<td>No robust, reproducible KCTD4-specific disease associations reported in surveyed sources; KCTD family members broadly linked to neurodevelopmental/neuropsychiatric disorders and cancers.</td>
<td style="text-align: right;">Review / proteomics (family-level)</td>
<td style="text-align: right;">2019, 2007</td>
<td>Family-level links: KCTD members implicated in NDDs, cancer, metabolic roles; isolated proteomic detection of KCTD4 in tumor-derived peptide data but no causal/clinical studies for KCTD4 found.</td>
<td>(teng2019kctdanew pages 4-7, alvarez2007analysisofthe pages 7-9)</td>
</tr>
<tr>
<td>Notable 2023‚Äì2024 developments relevant to KCTD4 context</td>
<td>2023: experimental evidence of extensive KCTD hetero-oligomerization (including KCTD4 as a KCTD5 interactor); 2024: structural/AlphaFold analysis predicts KCTD4 pentamer and poor Cul3 binding.</td>
<td style="text-align: right;">Primary / in silico</td>
<td style="text-align: right;">2023‚Äì2024</td>
<td>Key updates: Liao et al. (2023) experimentally mapped hetero-oligomers; Balasco et al. (2024) provided AF‚Äëbased KCTD‚ÄìCul3 interaction landscape placing KCTD4 in a pentameric, likely non‚ÄëCul3‚Äëbinding cluster.</td>
<td>(liao2023kctd5formsheterooligomeric pages 9-10, balasco2024acomprehensiveanalysis pages 8-9) https://doi.org/10.3390/ijms241814317 (liao2023kctd5formsheterooligomeric pages 9-10), https://doi.org/10.3390/ijms25031881 (balasco2024acomprehensiveanalysis pages 8-9)</td>
</tr>
</tbody>
</table>
<p><em>Table: Concise, sourced evidence table summarizing what is known about human KCTD4 (UniProt Q8WVF5), covering identity, domains, oligomeric state, interactions, localization, expression, pathway context, disease links, and key 2023‚Äì2024 updates. Each row cites the specific sources used (context IDs).</em></p>
<p>Recent developments (2023‚Äì2024) and latest research<br />
- Structural/Cul3 binding landscape (2024): An in silico structural survey using AlphaFold-guided modeling reported that KCTD4 forms a pentameric assembly (Cluster 4) but does not produce a reliable, meaningful complex with Cul3; predicted KCTD4‚ÄìCul3 complexes showed poor confidence/PAE profiles relative to confirmed Cul3-interacting KCTDs (International Journal of Molecular Sciences, 2024; DOI: https://doi.org/10.3390/ijms25031881) (balasco2024acomprehensiveanalysis pages 8-9).<br />
- Hetero-oligomerization within the family (2023): KCTD5 was shown to form hetero-oligomeric complexes with multiple KCTD members across clades. The interaction dataset from co-IP and BRET assays included KCTD4 as a hetero-oligomeric partner of KCTD5, indicating that KCTD4 can participate in mixed KCTD assemblies (Int. J. Mol. Sci., 2023; DOI: https://doi.org/10.3390/ijms241814317) (liao2023kctd5formsheterooligomeric pages 9-10).<br />
- GPCR/GŒ≤Œ≥ regulatory context (2023): Multiple KCTDs (e.g., KCTD2/5/17) were demonstrated to bind GŒ≤Œ≥ and suppress cAMP sensitization in reconstituted systems and neurons. KCTD4 was included as a phylogenetically distinct comparator in neuronal assays, but the study did not present direct biochemical evidence of KCTD4‚ÄìGŒ≤Œ≥ binding; thus, KCTD4‚Äôs GŒ≤Œ≥ interaction remains unproven (Journal of Biological Chemistry, 2023; DOI: https://doi.org/10.1016/j.jbc.2023.102924) (sloan2023multiplepotassiumchannel pages 7-10).</p>
<p>Molecular function, interactions, and pathways (KCTD4-specific and by-close analogy)<br />
- Oligomeric state: KCTD4 is predicted to assemble as a pentamer, consistent with the predominant pentameric architecture found in many KCTDs and supported by the 2024 structural clustering (balasco2024acomprehensiveanalysis pages 8-9).<br />
- Cul3/E3-ligase adaptor potential: Current AF-based modeling suggests KCTD4 is unlikely to form a stable Cul3 complex, in contrast to many Cul3-binding KCTDs; therefore, a primary role as a Cul3 adaptor remains unsubstantiated for KCTD4 (balasco2024acomprehensiveanalysis pages 8-9). Family reviews emphasize that Cul3 binding is not universal across BTB proteins, so the BTB fold alone does not guarantee Cul3 engagement (teng2019kctdanew pages 4-7, david2018gababreceptorassociatedkctd pages 14-17).<br />
- GABAB receptor machinery: KCTD4 is not part of the GABAB auxiliary subunit subclade (KCTD8/12/16). KCTD8/16 can bind Cul3 via non-BTB C-terminal H2 regions and link CRL3 to GABAB, a mechanism not known for KCTD4 (david2018gababreceptorassociatedkctd pages 35-39, david2018gababreceptorassociatedkctd pages 14-17).<br />
- GŒ≤Œ≥ and GPCR signaling: Direct binding of KCTD4 to GŒ≤Œ≥ has not been established in the surveyed 2023‚Äì2024 work; other KCTDs clearly bind GŒ≤Œ≥ and attenuate cAMP sensitization, highlighting a plausible but unproven analogy for KCTD4 (sloan2023multiplepotassiumchannel pages 7-10). <br />
- Hetero-oligomeric assemblies: KCTD5‚ÄìKCTD4 associations detected by co-IP/BRET suggest KCTD4 can contribute to mixed KCTD complexes, potentially influencing the assembly and localization of larger KCTD networks (liao2023kctd5formsheterooligomeric pages 9-10).</p>
<p>Cellular localization and expression<br />
- Localization: KCTD proteins are soluble intracellular proteins; KCTD4-specific localization was not reported in the reviewed texts. Thus, cytosolic/intracellular residence is inferred at family level pending direct KCTD4 mapping (sokolina2014humangpcrinteractome pages 53-56, david2018gababreceptorassociatedkctd pages 14-17).<br />
- Expression evidence from immunopeptidomics: A proteomics study of an HLA class I peptidome from a hepatocellular carcinoma line listed a KCTD4 (Q8WVF5) peptide among identified antigens, indicating expression sufficient for antigen processing and presentation in that context (Proteomics Clinical Applications, 2007; DOI: https://doi.org/10.1002/prca.200600388) (alvarez2007analysisofthe pages 7-9).</p>
<p>Disease links, applications, and real-world implementations<br />
- Disease associations (KCTD4-specific): Robust disease-specific literature for KCTD4 is scarce in the surveyed sources. The HLA peptidome detection provides evidence of expression in a tumor cell line setting but does not establish causal roles (alvarez2007analysisofthe pages 7-9).<br />
- Family-level disease context: KCTD family proteins are linked to neurodevelopmental/neuropsychiatric disorders and cancers; however, these associations are member-specific, and extrapolation to KCTD4 requires direct evidence (teng2019kctdanew pages 4-7). GABAB-associated KCTDs and Cul3-interacting KCTDs have clearer roles; KCTD4 does not fall squarely into either evidenced category (david2018gababreceptorassociatedkctd pages 14-17, balasco2024acomprehensiveanalysis pages 8-9).<br />
- Practical implications: The 2023 demonstration that KCTD4 can hetero-oligomerize with KCTD5 suggests potential for KCTD4 to modulate multi-KCTD complexes implicated in GPCR or ubiquitin signaling in a tissue-specific manner, but concrete pathway-level applications for KCTD4 remain to be defined experimentally (liao2023kctd5formsheterooligomeric pages 9-10).</p>
<p>Expert opinions and authoritative analyses<br />
- Authoritative reviews emphasize the diversity of KCTD functions and caution against assuming Cul3 binding based solely on the BTB fold. Structural and biochemical validation is required member-by-member, a principle that applies directly to KCTD4 (teng2019kctdanew pages 4-7, david2018gababreceptorassociatedkctd pages 14-17, sokolina2014humangpcrinteractome pages 53-56). <br />
- The AlphaFold-guided Cul3 interaction survey (2024) provides a current, systematic perspective that KCTD4 is among likely non-interactors with Cul3‚Äîan inference that narrows functional hypotheses and focuses future experimental work (balasco2024acomprehensiveanalysis pages 8-9).</p>
<p>Relevant statistics and data<br />
- 2024 AF-based survey: Reliable KCTD‚ÄìCul3 models were obtained for 15 KCTDs known to interact with Cul3; KCTD4 was categorized among non-interactors with ‚Äúmeaningless‚Äù complex predictions (qualitative PAE/confidence assessment) (balasco2024acomprehensiveanalysis pages 8-9).<br />
- 2023 hetero-oligomerization screen: KCTD5 formed interactions with numerous KCTDs in co‚ÄëIP and BRET; KCTD4 was among detected partners, indicating cross-family hetero-assembly potential in cells (qualitative detection in multiple assays) (liao2023kctd5formsheterooligomeric pages 9-10).<br />
- 2023 GŒ≤Œ≥/cAMP studies: Multiple KCTDs demonstrated GŒ≤Œ≥ binding and functional suppression of cAMP sensitization; KCTD4 was included as a comparator in neuronal assays without presentation of direct binding data (sloan2023multiplepotassiumchannel pages 7-10).<br />
- 2007 immunopeptidomics: KCTD4 (Q8WVF5) peptides detected within the HLA-I repertoire of a hepatocellular carcinoma line, evidencing protein processing/presentation (catalog listing; qualitative) (alvarez2007analysisofthe pages 7-9).</p>
<p>Summary assessment of KCTD4 function and next steps<br />
- Most consistent, recent evidence supports KCTD4 as a pentameric BTB/T1-domain protein capable of forming hetero-oligomeric complexes (e.g., with KCTD5), but without current evidence for stable Cul3 binding or GABAB auxiliary function. Family-level paradigms (CRL3 adaptor and GPCR/GŒ≤Œ≥ modulation) remain plausible frameworks; however, KCTD4‚Äôs placement appears currently outside the established GABAB subclade and outside the Cul3-engaging cohort by structural prediction, narrowing the hypotheses for its primary function (balasco2024acomprehensiveanalysis pages 8-9, liao2023kctd5formsheterooligomeric pages 9-10, david2018gababreceptorassociatedkctd pages 14-17, teng2019kctdanew pages 4-7).<br />
- Priorities for functional annotation: (i) biochemistry of KCTD4‚ÄìCul3 (co-IP, in vitro reconstitution) to confirm or refute non-binding predictions; (ii) direct tests of KCTD4‚ÄìGŒ≤Œ≥ interaction and functional effects on AC isoforms; (iii) mapping subcellular localization and interactomes across tissues; (iv) targeted expression analyses (e.g., GTEx, proteomics) and genetic association screens to identify disease links.</p>
<p>Cited sources with URLs and dates<br />
- Teng et al., 2019, CNS Neuroscience &amp; Therapeutics (review): KCTD family overview; BTB/T1 domain, oligomerization, Cul3 adaptors, and GABAB subclade context. DOI: https://doi.org/10.1111/cns.13156 (June 2019) (teng2019kctdanew pages 4-7).<br />
- Berner (David), 2018, University of Basel (thesis/preprint): GABAB-associated KCTDs; evidence that KCTD8/16 link Cul3 via non-BTB H2 domains and recruit CRL3 to GABAB; KCTD12 not recruiting; KCTD4 not in GABAB subclade. DOI: https://doi.org/10.5451/unibas-006803142 (2018) (david2018gababreceptorassociatedkctd pages 35-39, david2018gababreceptorassociatedkctd pages 14-17).<br />
- Sokolina, 2014 (thesis): Family-level BTB/T1 information; note on limited KCTD4-specific literature at that time. URL not provided in extract (2014) (sokolina2014humangpcrinteractome pages 53-56).<br />
- Liao et al., 2023, International Journal of Molecular Sciences: KCTD5 forms hetero-oligomers across the KCTD family, including with KCTD4 (co‚ÄëIP and BRET). DOI: https://doi.org/10.3390/ijms241814317 (September 2023) (liao2023kctd5formsheterooligomeric pages 9-10).<br />
- Sloan et al., 2023, Journal of Biological Chemistry: Multiple KCTDs bind GŒ≤Œ≥ and modulate cAMP; KCTD4 included as a phylogenetically distinct comparator; no direct KCTD4‚ÄìGŒ≤Œ≥ binding reported. DOI: https://doi.org/10.1016/j.jbc.2023.102924 (March 2023) (sloan2023multiplepotassiumchannel pages 7-10).<br />
- Balasco et al., 2024, International Journal of Molecular Sciences: AF-based KCTD‚ÄìCul3 complex modeling; KCTD4 predicted pentamer and likely Cul3 non-interactor. DOI: https://doi.org/10.3390/ijms25031881 (February 2024) (balasco2024acomprehensiveanalysis pages 8-9).<br />
- Alvarez et al., 2007, Proteomics Clinical Applications: HLA class I peptidome from hepatocellular carcinoma line; KCTD4 (Q8WVF5) peptides detected. DOI: https://doi.org/10.1002/prca.200600388 (March 2007) (alvarez2007analysisofthe pages 7-9).</p>
<p>Notes on literature limitations and symbol ambiguity<br />
- The gene symbol ‚ÄúKCTD4‚Äù in human (Q8WVF5) appears non-ambiguous in the surveyed corpus; however, KCTD4-specific mechanistic literature is limited. Where KCTD4-specific data were unavailable, we explicitly labeled family-level inferences and avoided unjustified extrapolation (sokolina2014humangpcrinteractome pages 53-56, teng2019kctdanew pages 4-7).</p>
<p>References</p>
<ol>
<li>
<p>(teng2019kctdanew pages 4-7): Xinchen Teng, Abdel Aouacheria, Lo√Øc Lionnard, Kyle A. Metz, Lucian Soane, Atsushi Kamiya, and J. Marie Hardwick. Kctd: a new gene family involved in neurodevelopmental and neuropsychiatric disorders. CNS Neuroscience &amp; Therapeutics, 25:887-902, Jun 2019. URL: https://doi.org/10.1111/cns.13156, doi:10.1111/cns.13156. This article has 130 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(sokolina2014humangpcrinteractome pages 53-56): E Sokolina. Human gpcr interactome and investigation of the kctd/Œ≤2-adrenergic receptor interactions. Unknown journal, 2014.</p>
</li>
<li>
<p>(liao2023kctd5formsheterooligomeric pages 9-10): Yini Liao, Douglas C. Sloan, Josephine H. Widjaja, and Brian S. Muntean. Kctd5 forms hetero-oligomeric complexes with various members of the kctd protein family. International Journal of Molecular Sciences, 24:14317, Sep 2023. URL: https://doi.org/10.3390/ijms241814317, doi:10.3390/ijms241814317. This article has 9 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(balasco2024acomprehensiveanalysis pages 8-9): Nicole Balasco, Luciana Esposito, Giovanni Smaldone, Marco Salvatore, and Luigi Vitagliano. A comprehensive analysis of the structural recognition between kctd proteins and cullin 3. International Journal of Molecular Sciences, 25:1881, Feb 2024. URL: https://doi.org/10.3390/ijms25031881, doi:10.3390/ijms25031881. This article has 12 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(david2018gababreceptorassociatedkctd pages 14-17): David Berner. Gabab receptor-associated kctd proteins as molecular linkers to downstream signaling complexes. ArXiv, 2018. URL: https://doi.org/10.5451/unibas-006803142, doi:10.5451/unibas-006803142. This article has 0 citations.</p>
</li>
<li>
<p>(sloan2023multiplepotassiumchannel pages 7-10): Douglas C. Sloan, Casey E. Cryan, and Brian S. Muntean. Multiple potassium channel tetramerization domain (kctd) family members interact with gŒ≤Œ≥, with effects on camp signaling. Journal of Biological Chemistry, 299:102924, Mar 2023. URL: https://doi.org/10.1016/j.jbc.2023.102924, doi:10.1016/j.jbc.2023.102924. This article has 23 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(alvarez2007analysisofthe pages 7-9): I√±aki Alvarez, Montserrat Carrascal, Francesc Canals, Laia Muix√≠, Joaqu√≠n Abi√°n, and Dolores Jaraquemada. Analysis of the hla class i associated peptide repertoire in a hepatocellular carcinoma cell line reveals tumor‚Äêspecific peptides as putative targets for immunotherapy. PROTEOMICS ‚Äì Clinical Applications, 1:286-298, Mar 2007. URL: https://doi.org/10.1002/prca.200600388, doi:10.1002/prca.200600388. This article has 9 citations.</p>
</li>
<li>
<p>(david2018gababreceptorassociatedkctd pages 35-39): David Berner. Gabab receptor-associated kctd proteins as molecular linkers to downstream signaling complexes. ArXiv, 2018. URL: https://doi.org/10.5451/unibas-006803142, doi:10.5451/unibas-006803142. This article has 0 citations.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>balasco2024acomprehensiveanalysis pages 8-9</li>
<li>sloan2023multiplepotassiumchannel pages 7-10</li>
<li>alvarez2007analysisofthe pages 7-9</li>
<li>teng2019kctdanew pages 4-7</li>
<li>sokolina2014humangpcrinteractome pages 53-56</li>
<li>david2018gababreceptorassociatedkctd pages 14-17</li>
<li>david2018gababreceptorassociatedkctd pages 35-39</li>
<li>https://doi.org/10.3390/ijms25031881</li>
<li>https://doi.org/10.1016/j.jbc.2023.102924</li>
<li>https://doi.org/10.3390/ijms241814317</li>
<li>https://doi.org/10.1002/prca.200600388</li>
<li>https://doi.org/10.1111/cns.13156</li>
<li>https://doi.org/10.5451/unibas-006803142</li>
<li>https://doi.org/10.1111/cns.13156,</li>
<li>https://doi.org/10.3390/ijms241814317,</li>
<li>https://doi.org/10.3390/ijms25031881,</li>
<li>https://doi.org/10.5451/unibas-006803142,</li>
<li>https://doi.org/10.1016/j.jbc.2023.102924,</li>
<li>https://doi.org/10.1002/prca.200600388,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(KCTD4-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8WVF5" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: false<br />
start_time: '2025-12-27T21:56:48.017432'<br />
end_time: '2025-12-27T22:13:04.006609'<br />
duration_seconds: 975.99<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: KCTD4<br />
  gene_symbol: KCTD4<br />
  uniprot_accession: Q8WVF5<br />
  protein_description: 'RecName: Full=BTB/POZ domain-containing protein KCTD4;'<br />
  gene_info: Name=KCTD4;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: BTB/POZ_dom. (IPR000210); KCTD4_C. (IPR045740); SKP1/BTB/POZ_sf.<br />
    (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 124</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8WVF5</li>
<li><strong>Protein Description:</strong> RecName: Full=BTB/POZ domain-containing protein KCTD4;</li>
<li><strong>Gene Information:</strong> Name=KCTD4;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> BTB/POZ_dom. (IPR000210); KCTD4_C. (IPR045740); SKP1/BTB/POZ_sf. (IPR011333); T1-type_BTB. (IPR003131); BTB_2 (PF02214)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "KCTD4" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'KCTD4' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>KCTD4</strong> (gene ID: KCTD4, UniProt: Q8WVF5) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="kctd4-structure-function-and-emerging-roles-in-human-biology">KCTD4: Structure, Function, and Emerging Roles in Human Biology</h1>
<h2 id="key-concepts-and-protein-characteristics">Key Concepts and Protein Characteristics</h2>
<p><strong>Gene Identity:</strong> KCTD4 (Potassium Channel Tetramerization Domain-containing protein 4) is a human gene encoding a BTB/POZ domain-containing protein (UniProt Q8WVF5). The KCTD4 protein is named for its N-terminal <strong>BTB/POZ domain</strong> ‚Äì a <strong>Broad Complex, Tramtrack, and Bric-√†-brac (BTB)</strong> fold also known as a <strong>POZ domain</strong>, originally identified as a tetramerization motif in voltage-gated potassium channels (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD">pmc.ncbi.nlm.nih.gov</a>). Despite the name suggesting a tetramer, KCTD family proteins often assemble as pentamers; for example, the crystal structure of the related KCTD5 revealed a five-subunit oligomer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD">pmc.ncbi.nlm.nih.gov</a>). KCTD4 is <strong>predicted to form homooligomers</strong> via identical protein binding (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more">www.genecards.org</a>), consistent with structural analyses indicating KCTD4‚Äôs BTB domain mediates a stable pentameric assembly (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the">pmc.ncbi.nlm.nih.gov</a>). This oligomerization likely provides a platform for protein‚Äìprotein interactions. KCTD4‚Äôs C-terminus is a unique region (InterPro: KCTD4_C) distinct from other family members, suggesting it may confer specific binding partners or functions to KCTD4. </p>
<p><strong>Protein Domain and Family:</strong> The defining BTB/POZ domain at KCTD4‚Äôs N-terminus (~residues 1‚Äì135) facilitates <strong>protein‚Äìprotein interactions and self-assembly</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all">pmc.ncbi.nlm.nih.gov</a>). In general, BTB domains enable KCTD proteins to form homo-oligomers (e.g. pentamers) or to recruit other proteins into complexes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all">pmc.ncbi.nlm.nih.gov</a>). KCTD4 belongs to the <strong>KCTD family</strong> of proteins, which all share the BTB domain but have divergent C-termini that drive different functions. This family does <em>not</em> actually function as ion channel subunits; rather, the ‚Äútetramerization domain‚Äù nomenclature reflects structural homology to potassium channel subunits. KCTD proteins have been functionally linked to diverse cellular processes: some act as adaptors in <strong>Cullin-3 ubiquitin ligase complexes</strong>, others regulate G-protein-coupled receptor signaling, and some modulate neuronal receptor activity (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15">journals.plos.org</a>) (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=KCTDs%20such%20as%20KCTD6%20and,also%20substrate%20adaptor%20for%20Cul3">journals.plos.org</a>). For instance, certain KCTDs (like KCTD6 and KCTD11) bind Cullin-3 to target specific substrates for ubiquitination (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L117%20KCTDs%20such,also%20substrate%20adaptor%20for%20Cul3">journals.plos.org</a>), while others (KCTD8/12/16) associate with GABA<sub>B</sub> receptors to alter channel desensitization (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15">journals.plos.org</a>). KCTD4‚Äôs precise physiological role has only begun to be elucidated in recent years, but it appears to <strong>deviate from the classic Cullin-3 adaptor paradigm</strong> (see below). </p>
<p><strong>Expression and Localization:</strong> KCTD4 is an <strong>intracellular protein</strong> with a tissue-enriched expression profile. mRNA surveys indicate that KCTD4 is <strong>preferentially expressed in the brain</strong>, with high expression in neuronal tissues and lower levels in most other tissues (<a href="https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY">www.proteinatlas.org</a>). In the Human Protein Atlas, KCTD4 is classified as <strong>‚Äútissue-enriched (brain)‚Äù</strong> and clusters with genes involved in neuronal signaling (<a href="https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY">www.proteinatlas.org</a>). This suggests a role in the nervous system, potentially modulating neural signaling pathways. Consistent with being a BTB-domain protein, KCTD4 is predicted to localize to the cytoplasm (no signal peptide or transmembrane regions) (<a href="https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some">www.proteinatlas.org</a>). There is evidence that KCTD4 may form complexes near the cell membrane or cytoskeleton when binding its partners (for example, binding to membrane-associated channels as described below). No enzymatic activity has been attributed to KCTD4 ‚Äì it likely functions as a <strong>scaffold or adaptor</strong>, mediating interactions between other proteins. </p>
<p><strong>Protein Family Context:</strong> Phylogenetically, KCTD4 is somewhat unique within the KCTD family. Earlier bioinformatic analyses grouped most human KCTDs into several clades (A through G), but <strong>KCTD4 did not clearly fit into those major clades</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that">pmc.ncbi.nlm.nih.gov</a>). It clusters with a small subset of atypical KCTDs (including KCTD18 and KCTD19) that have divergent domain architectures (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that">pmc.ncbi.nlm.nih.gov</a>). Notably, KCTD4 and KCTD19 are <strong>‚ÄúCullin-3 non-interactors‚Äù</strong> ‚Äì unlike many BTB proteins, they do not stably bind the Cullin-3 E3 ligase scaffold (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the">pmc.ncbi.nlm.nih.gov</a>). A recent structural modeling study (2024) confirmed that KCTD4‚Äôs BTB domain fails to form a meaningful complex with Cullin-3, suggesting KCTD4 has lost or never acquired the Cullin-binding interface (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural">pmc.ncbi.nlm.nih.gov</a>). This distinguishes KCTD4 from Cullin-binding adaptors and implies its biological function is executed through alternate interactions (e.g. binding ion channel regulators or signaling proteins rather than ubiquitin ligase machinery). In summary, KCTD4 is <strong>believed to act as a protein interaction hub</strong>, oligomerizing via its BTB domain and recruiting other molecules into complex, in order to regulate signaling pathways rather than directly catalyzing biochemical reactions.</p>
<h2 id="recent-developments-and-latest-research-20232024">Recent Developments and Latest Research (2023‚Äì2024)</h2>
<p><strong>KCTD4 in Calcium Signaling and Cancer Metastasis:</strong> One of the most significant recent advances in understanding KCTD4 came from a 2023 study by Zheng <em>et al.</em> (published in <em>Acta Pharmaceutica Sinica B</em>) examining metastasis in esophageal cancer (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes">pubmed.ncbi.nlm.nih.gov</a>). This study identified <strong>KCTD4 as a driver of cancer metastasis</strong> in esophageal squamous cell carcinoma (ESCC) via an unexpected calcium signaling mechanism (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes">pubmed.ncbi.nlm.nih.gov</a>). The researchers found KCTD4 mRNA and protein to be <strong>upregulated in metastatic ESCC tumors</strong> compared to primary tumors, and high KCTD4 expression in patient samples correlated with significantly poorer survival outcomes (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a">pubmed.ncbi.nlm.nih.gov</a>). In functional experiments, manipulating KCTD4 levels altered cancer cell behavior: <strong>KCTD4 overexpression enhanced metastatic traits</strong> (increasing cell invasion and dissemination in mouse models), whereas KCTD4 knockdown suppressed these traits (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C">pubmed.ncbi.nlm.nih.gov</a>). Mechanistically, KCTD4 was shown to bind a chloride channel protein called <strong>CLIC1 (Chloride Intracellular Channel 1)</strong> and disrupt CLIC1‚Äôs normal dimerization (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>). CLIC1 normally can form chloride channel dimers, and KCTD4‚Äôs interference with this process led to aberrant ionic homeostasis ‚Äì specifically, it caused an <strong>increase in intracellular Ca<sup>2+</sup> levels</strong> (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>). The elevated Ca<sup>2+</sup> activated the Ca-dependent transcription factor <strong>NFATc1</strong>, which in turn drove the overproduction of <strong>fibronectin</strong>, an extracellular matrix protein (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>). This KCTD4‚ÄìCLIC1‚ÄìCa<sup>2+</sup>‚ÄìNFAT‚Äìfibronectin axis creates a pro-metastatic microenvironment: the excess fibronectin secreted by cancer cells stimulates surrounding fibroblasts (connective tissue cells) in a paracrine fashion, and those activated fibroblasts secrete factors (notably <strong>MMP24</strong>, a matrix metalloproteinase) that feed back to further enhance cancer cell invasion (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>). In summary, the 2023 study uncovered a novel <strong>signaling pathway involving KCTD4 as an upstream regulator of calcium signaling and tumor-stroma interaction</strong>. This is a striking discovery because it links a BTB-domain protein to calcium homeostasis: <strong>KCTD4 essentially hijacks an ion channel (CLIC1) to raise Ca<sup>2+</sup> levels and promote metastasis</strong> (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>). The authors highlighted KCTD4 as a promising prognostic biomarker and a potential therapeutic target in ESCC (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC">pubmed.ncbi.nlm.nih.gov</a>), given that its expression correlates with metastasis and survival.</p>
<p><strong>Therapeutic Targeting of KCTD4‚ÄìCLIC1 Interaction:</strong> Alongside the mechanistic findings, the same 2023 ESCC study explored ways to counteract KCTD4‚Äôs pro-metastatic function. The researchers performed a small-molecule screen and identified a <strong>lead compound ‚ÄúK279-0738‚Äù</strong> that can bind to the KCTD4‚ÄìCLIC1 complex (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=secretion%20activates%20fibroblasts%20in%20a,and%20therapeutic%20target%20for%20ESCC">pubmed.ncbi.nlm.nih.gov</a>). K279-0738 was shown to <strong>disrupt the KCTD4‚ÄìCLIC1 interaction</strong>, thereby reversing the downstream effects on Ca<sup>2+</sup> signaling. In cell-based assays, this compound reduced the excessive Ca<sup>2+</sup> influx caused by KCTD4 and significantly <strong>inhibited cancer cell invasion</strong> in a dose-dependent manner (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs">pmc.ncbi.nlm.nih.gov</a>). Importantly, in an <strong>in vivo metastasis model</strong> (mice injected with ESCC cells), treatment with K279-0738 led to a <strong>marked reduction in metastatic tumor burden in the lungs</strong>, without obvious toxicity to the animals (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs">pmc.ncbi.nlm.nih.gov</a>). These results provide a proof-of-concept that targeting KCTD4‚Äôs interactions can suppress metastasis. While K279-0738 is a research compound, its efficacy in preclinical tests suggests that <strong>KCTD4‚ÄìCLIC1 is a druggable interface</strong>. Ongoing efforts are likely focusing on optimizing such inhibitors. This is a real-world implementation of KCTD4 research: translating the mechanistic insights into a therapeutic strategy. The 2023 study therefore not only advanced basic understanding of KCTD4‚Äôs function but also identified a tangible <strong>application in cancer therapy</strong>, underlining the gene‚Äôs medical relevance (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>KCTD4 and G-Protein Signaling:</strong> Another important development in 2023 was the discovery that KCTD4 may play a role in G-protein coupled receptor (GPCR) signaling pathways. A study by Sloan <em>et al.</em> (J. Biol. Chem., 2023) examined multiple KCTD family members and their ability to interact with G-protein Œ≤Œ≥ subunits (the dissociable components of heterotrimeric G-proteins) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L217%20three%20weak,2D">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=synthesized%20from%20mouse%20complementary%20DNA,the%20EcoRV%20site%20preceding%20the">pmc.ncbi.nlm.nih.gov</a>). In that study, KCTD4 was found to <strong>physically associate with GŒ≤Œ≥</strong>, albeit relatively weakly compared to some other KCTDs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=three%20weak%20binders%20,2D">pmc.ncbi.nlm.nih.gov</a>). Despite the weaker binding, the functional impact of KCTD4 was noticeable: when KCTD4 was overexpressed in neuronal cells, it significantly <strong>attenuated GPCR signaling responses</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>). Specifically, KCTD4 expression reduced the accumulation of cAMP in neurons stimulated by dopamine (a GPCR agonist), indicating that KCTD4 can dampen GŒ±<sub>s</sub>-coupled receptor signaling downstream of GŒ≤Œ≥ (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>). In quantitative terms, the <strong>net cAMP production was significantly lower</strong> in cells with exogenous KCTD4 compared to controls (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively">pmc.ncbi.nlm.nih.gov</a>). Notably, even though KCTD4‚Äôs interaction with GŒ≤Œ≥ was biochemically weaker, it still exerted a <strong>potent functional effect on signal transduction</strong>, similar to other KCTDs that bind more strongly (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>). This suggests KCTD4 might sequester or modulate GŒ≤Œ≥ in a way that prevents full activation of adenylyl cyclase (thus blunting cAMP generation). The <strong>implication</strong> is that in a physiological setting (likely in the brain, where KCTD4 is enriched), KCTD4 could regulate neuronal GPCR pathways ‚Äì for example, tuning the sensitivity of neurons to neurotransmitters by modulating second-messenger signaling. This finding expands the functional repertoire of KCTD4 beyond the context of cancer: it positions KCTD4 as part of a broader signal modulation network, potentially involved in <strong>neuromodulatory processes</strong>. It is also consistent with KCTD4‚Äôs brain-specific expression, linking its presence in neurons to a role in <strong>synaptic or circuit signaling plasticity</strong>. The JBC study underscores that <strong>multiple KCTD proteins (including KCTD4)</strong> intersect with GPCR/G-protein signaling, an area of significant interest for both neuroscience and pharmacology (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Structural Insights (2024):</strong> In early 2024, a comprehensive analysis by Balasco <em>et al.</em> (Int. J. Mol. Sci., 2024) used AlphaFold2 modeling and available experimental data to map how various KCTD proteins interface with Cullin-3 ubiquitin ligase (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,significance%20of%20these%20faint%20complexes">pmc.ncbi.nlm.nih.gov</a>). Although the focus was on Cullin-3, this study reinforced some key points about KCTD4‚Äôs structure and interactions. The authors placed KCTD4 in a category of KCTDs that form <strong>stable pentamers</strong> but do <strong>not bind Cullin-3</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the">pmc.ncbi.nlm.nih.gov</a>). AlphaFold predictions yielded a ‚Äúmeaningless complex‚Äù for a hypothetical KCTD4‚ÄìCul3 interaction, indicating that KCTD4‚Äôs BTB domain lacks the necessary interface to dock onto Cul3 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural">pmc.ncbi.nlm.nih.gov</a>). This aligns with earlier experimental observations and suggests that <strong>KCTD4‚Äôs BTB domain has a different interaction specificity</strong> compared to Cul3-binding BTB domains. Instead of recruiting ubiquitin ligase machinery, KCTD4‚Äôs pentameric BTB assembly likely recruits other protein partners (such as CLIC1 or G-protein subunits as noted above). The structural study grouped KCTD4 with KCTD19 in ‚ÄúCluster 4,‚Äù highlighting a shared unusual feature: KCTD19 contains multiple BTB repeats and also fails to bind Cul3 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the">pmc.ncbi.nlm.nih.gov</a>). These insights from 2024 provide a more <strong>confident structural understanding</strong> of KCTD4: it confirms the oligomeric state (5:5 pentamer) and clarifies the absence of ubiquitin ligase interaction, thereby focusing future research on the <em>true</em> binding partners and functions of KCTD4. In essence, the structural perspective has caught up with the functional data, painting a coherent picture of KCTD4 as an <strong>adapter protein that assembles as a pentameric complex to carry out non-canonical BTB-protein functions</strong>.</p>
<h2 id="functional-role-and-biological-pathways">Functional Role and Biological Pathways</h2>
<p><strong>Signal Transduction and Adaptor Function:</strong> Current evidence suggests KCTD4 acts primarily as a <strong>molecular adaptor/regulator in signaling pathways</strong> rather than an enzyme or structural scaffold. Its BTB domain-mediated oligomer allows KCTD4 to present multiple interaction interfaces. Recent findings connect KCTD4 to at least two key pathways:</p>
<ul>
<li>
<p><strong>Calcium/NFAT Signaling Axis:</strong> KCTD4‚Äôs interaction with the chloride channel CLIC1 in ESCC cells indicates a role in ion homeostasis and Ca<sup>2+</sup>-triggered transcription (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>). By disrupting CLIC1, KCTD4 causes an elevation in intracellular calcium, which activates the <strong>NFATc1 transcription factor</strong>. NFATc1 then upregulates <strong>fibronectin</strong>, impacting cell‚Äìmatrix interactions and the tumor microenvironment (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>). This places KCTD4 upstream of a Ca<sup>2+</sup>-NFAT-fibronectin signaling cascade that can drive cellular migration and invasion.</p>
</li>
<li>
<p><strong>G-Protein/cAMP Pathway:</strong> KCTD4‚Äôs interaction with GŒ≤Œ≥ implicates it in GPCR signaling modulation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>). It appears to function analogous to other known GŒ≤Œ≥-binding proteins (like phosducin or certain AGS proteins) that sequester GŒ≤Œ≥. By binding GŒ≤Œ≥, KCTD4 can reduce the activation of adenylyl cyclase (AC) and thus <strong>dampen cAMP production</strong> following GPCR stimulation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively">pmc.ncbi.nlm.nih.gov</a>). This effect on the cAMP/PKA pathway could influence processes like neurotransmitter signaling in neurons or hormonal responses in other cells. Notably, GeneCards pathway annotations have linked KCTD4 to ‚Äúsweet taste signaling‚Äù and ‚ÄúcAMP-dependent PKA activation,‚Äù which likely reflects this emerging connection to GPCR/G-protein signaling (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21">www.genecards.org</a>). In neurons, KCTD4 might fine-tune responses to neuromodulators (e.g., dopamine or other neurotransmitters that work via G<sub>s/i</sub>-coupled receptors), potentially affecting neuronal excitability or synaptic plasticity.</p>
</li>
</ul>
<p>Beyond these pathways, less direct evidence hints that KCTD4 could participate in additional cellular processes. High-throughput genetic screens have flagged KCTD4 in various contexts ‚Äì for example, KCTD4 was a ‚Äúhit‚Äù in multiple CRISPR interference/activation screens (14 hits across &gt;1300 genome-wide screens) (<a href="https://www.ncbi.nlm.nih.gov/gene?cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=386618#:~:text=,CTD%3A%20Comparative%20Toxicogenomics%20Database">www.ncbi.nlm.nih.gov</a>). While these data lack detail, they suggest that perturbing KCTD4 expression impacts certain cellular phenotypes (possibly cell growth or stress responses) in diverse settings. <strong>Protein interaction databases</strong> (e.g., BioGRID) list a few candidate interactors of KCTD4 (aside from CLIC1 and GŒ≤Œ≥), though comprehensive interactome studies are still needed. Given the BTB domain‚Äôs propensity to mediate <strong>protein oligomerization and multimeric complex formation</strong>, it is plausible that KCTD4 engages in assemblies with other signaling proteins or cytoskeletal elements. For instance, some BTB proteins bind actin regulators or transcription factors; whether KCTD4 has such partners remains to be clarified. </p>
<p><strong>Cellular Localization of Function:</strong> KCTD4 is intracellular, and functional studies indicate its actions occur in the <strong>cytoplasm and at the membrane interface</strong>. The KCTD4‚ÄìCLIC1 interaction would presumably occur near membranes or within membrane-adjacent compartments, since CLIC1 can exist as a membrane channel. Indeed, disrupting CLIC1‚Äôs dimerization by KCTD4 may occur on endosomal or plasma membranes where CLIC1 is localized. Meanwhile, the consequence of that interaction (raising cytosolic Ca<sup>2+</sup>) suggests KCTD4 indirectly influences cytosolic Ca<sup>2+ </sup>levels ‚Äì a process that could also affect organelles like the endoplasmic reticulum (through store-operated calcium entry or other feedback). For the G-protein interaction, KCTD4 likely acts in the <strong>cytosol or at the inner face of the plasma membrane</strong>: GŒ≤Œ≥ subunits are released at the membrane upon GPCR activation, and KCTD4 could bind them either in the cytosol or as they diffuse in the inner leaflet near the receptor complex. There is no evidence that KCTD4 localizes to the nucleus; however, its impact on NFATc1 demonstrates it can influence nuclear events indirectly via second messengers. In summary, KCTD4 functions as a <strong>cytoplasmic signaling modulator</strong>, affecting membrane-proximal signaling events (ion channel activity, GPCR cascades) which then propagate to nuclear responses (gene transcription changes via NFAT, etc.).</p>
<h2 id="current-applications-and-real-world-implications">Current Applications and Real-World Implications</h2>
<p><strong>Cancer Biomarker Potential:</strong> KCTD4‚Äôs upregulation in metastatic ESCC and its correlation with patient prognosis highlight its potential utility as a <strong>biomarker in oncology</strong>. If validated in clinical cohorts, <strong>KCTD4 expression levels could serve as a prognostic indicator</strong> for ESCC ‚Äì patients with high tumor KCTD4 might be at higher risk of metastasis and poorer outcomes (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a">pubmed.ncbi.nlm.nih.gov</a>). This information could help stratify patients for more aggressive therapy or closer monitoring. Beyond esophageal cancer, preliminary data suggest KCTD4 may be aberrantly expressed in other cancers: a 2021 review of KCTD proteins in cancer noted that <strong>about 5% of lung adenocarcinoma samples showed KCTD4 overexpression</strong> relative to normal lung tissue (<a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001">biosignaling.biomedcentral.com</a>). In that analysis, KCTD4 had an average ~1.3-fold higher expression in a subset of lung tumors (51 of 1019 cases, p &lt; 0.001) (<a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001">biosignaling.biomedcentral.com</a>). While not prevalent in all patients, this indicates that in certain tumors KCTD4 is dysregulated. Such data point to a possible role of KCTD4 in tumor biology across multiple organs, warranting further investigation. At present, KCTD4 is not a standard clinical test, but research findings suggest it could become a part of a <strong>metastatic risk gene signature</strong> or a target for antibody-based detection in tissue biopsies. It‚Äôs worth noting that KCTD4 is not simply a passive marker; given its pro-metastatic function in ESCC, measuring KCTD4 might directly inform on a tumor‚Äôs invasive potential.</p>
<p><strong>Therapeutic Targeting:</strong> The discovery of the KCTD4‚ÄìCLIC1 interaction and the successful use of a small-molecule inhibitor (K279-0738) to block this interface open a door to <strong>therapeutic interventions</strong> targeting KCTD4. This is a relatively rare example of a BTB-domain protein being drugged. The lead compound K279-0738 significantly reduced metastasis in ESCC models (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs">pmc.ncbi.nlm.nih.gov</a>), suggesting that <strong>inhibitors of KCTD4</strong> could have anti-metastatic effects. In practical terms, this could translate to new treatments that prevent cancer spread by targeting tumor microenvironment interactions (in this case, the tumor‚Äìfibroblast signaling loop mediated by fibronectin and MMP24). Before reaching the clinic, such compounds would need optimization and safety profiling, but the concept is highly encouraging. Additionally, if KCTD4 is found to contribute to metastasis in other cancers (like lung or colon cancer), a KCTD4‚ÄìCLIC1 inhibitor or similar molecule could have broader anti-metastatic applications. Beyond small molecules, one might envision biologics: for example, an intracellular <strong>peptide that disrupts KCTD4 oligomerization</strong> or a targeted protein degrader (PROTAC) to eliminate KCTD4 in tumor cells. These approaches remain speculative, but the principle is that <strong>KCTD4 is now a validated target</strong> for intervention in at least one cancer context. </p>
<p><strong>Neurological Research and Other Applications:</strong> Since KCTD4 is enriched in the brain, there is interest in its role in the nervous system. While no neurological disorder has yet been directly linked to KCTD4, many KCTD family members are implicated in neuropsychiatric conditions (for instance, mutations in KCTD13 have been associated with autism spectrum disorder, and KCTD17 with myoclonus-dystonia). Given KCTD4‚Äôs involvement in GPCR/cAMP signaling, it‚Äôs plausible that <strong>KCTD4 could influence neurological processes</strong> like learning, memory, or sensory perception. The ‚Äúsweet taste signaling‚Äù pathway association (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21">www.genecards.org</a>) hints that KCTD4 might modulate taste receptor or other sensory GPCR signals, though this remains to be tested experimentally. If future studies reveal that KCTD4 affects neural circuitry or behavior, then KCTD4 could become a target for CNS drug development or a biomarker for certain neurological conditions. For instance, if KCTD4 regulates dopamine signaling (as suggested by the dopamine/cAMP experiment (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1">pmc.ncbi.nlm.nih.gov</a>)), it might impact conditions related to dopamine dysfunction, such as depression or Parkinson‚Äôs disease. These ideas are currently speculative, but they underscore the importance of KCTD4 beyond cancer. </p>
<p>In a more general biotechnology context, KCTD4 could be used as a tool in research. Its ability to bind GŒ≤Œ≥ and dampen GPCR signaling means that <strong>KCTD4 (or its BTB domain)</strong> might be exploited in experimental systems to tune GPCR responses. Researchers could overexpress KCTD4 in cell lines to globally reduce G-protein signaling and study downstream effects, providing a novel method to modulate signal transduction in vitro. Conversely, a dominant-negative mutant of KCTD4 (that oligomerizes but cannot bind its targets) could sequester native KCTD4 and thereby <em>enhance</em> GPCR signaling, serving as a probe of KCTD4‚Äôs physiological roles. These are potential laboratory applications that derive from KCTD4‚Äôs mechanistic properties.</p>
<h2 id="expert-opinions-and-analysis-from-authoritative-sources">Expert Opinions and Analysis from Authoritative Sources</h2>
<p>Scientific experts have increasingly pointed out the significance of BTB-domain KCTD proteins like KCTD4 in cell regulation. <strong>Structural biologists</strong> note that KCTD4 represents a subclass of KCTDs that likely evolved away from ubiquitin ligase activity and toward other functions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the">pmc.ncbi.nlm.nih.gov</a>). In a 2015 analysis of KCTDs, Smaldone <em>et al.</em> remarked that <strong>Cullin-3 recognition is not a universal property of KCTDs</strong>, highlighting that some family members (e.g. KCTD12, KCTD15) have lost the ability to bind the Cullin despite retaining the BTB domain (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost">journals.plos.org</a>). KCTD4 falls into this category of Cullin-independent KCTDs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural">pmc.ncbi.nlm.nih.gov</a>), which experts interpret as evidence that <strong>KCTDs have diversified in function</strong> more than initially appreciated. This expert view is that the BTB/POZ fold in proteins like KCTD4 has been repurposed for novel interactions beyond ubiquitination targets (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost">journals.plos.org</a>). Biochemists studying signal transduction have similarly pointed out the ‚Äúmoonlighting‚Äù roles of KCTDs. A 2023 commentary on Sloan <em>et al.</em> (JBC) emphasized that even <strong>weak GŒ≤Œ≥-binding KCTDs can profoundly affect GPCR signaling</strong>, suggesting a previously under-recognized layer of GPCR regulation by this protein family (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>). This reflects an emerging expert consensus that KCTD proteins serve as <strong>regulatory nodes in signaling networks</strong>, often assembling as multimeric complexes to buffer or scaffold signaling molecules. </p>
<p>Cancer biologists, in a 2021 review, drew attention to many KCTDs (including KCTD4) being misregulated in cancers and encouraged deeper investigation into their functions in oncogenesis. In that review, KCTD4 was noted for recurrent overexpression in datasets of lung cancer and other tumors (<a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001">biosignaling.biomedcentral.com</a>). The authors pointed out that <strong>KCTD proteins are an ‚Äúemerging class‚Äù of cancer-related proteins</strong>, either as tumor suppressors or oncogenic facilitators, and that understanding each KCTD‚Äôs role could reveal new therapeutic targets (<a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001">biosignaling.biomedcentral.com</a>). They specifically listed KCTD4 among genes whose expression is altered in cancer, implying that <strong>KCTD4 might contribute to tumorigenesis</strong> or tumor progression in certain contexts (<a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001">biosignaling.biomedcentral.com</a>). Expert analysis in that article and others suggests that KCTD4‚Äôs effect on fibronectin and the microenvironment (as shown later in 2023) could be a general mechanism by which some tumors co-opt stromal support. </p>
<p>From a protein science perspective, experts have also commented on the <strong>oligomerization properties</strong> of KCTD4. The fact that KCTD4 is pentameric was predicted in structural clustering studies (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the">pmc.ncbi.nlm.nih.gov</a>) and aligns with the general principle (noted by Z. Liu <em>et al.</em>, 2013) that KCTDs often self-assemble into higher-order oligomers via their BTB domains (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD">pmc.ncbi.nlm.nih.gov</a>). This multimeric assembly is considered functionally important: as noted in a 2017 Biochemical Journal article, different KCTD oligomers may create distinct avidity or cooperative binding effects, thereby tuning the strength of interactions with targets (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=S9B%2CC%2C%20and%20S10%20%29,is%20evident%20from%20AF%20predictions">pmc.ncbi.nlm.nih.gov</a>). For example, a pentameric KCTD4 might bind multiple CLIC1 subunits or multiple GŒ≤Œ≥ units simultaneously, giving it a unique leverage in modulating those proteins. Such expert insights underscore how <strong>structure underlies function</strong> for KCTD4 ‚Äì the pentameric quaternary structure is key to its ability to act as a signaling hub. </p>
<p>Finally, experts in chemical biology have weighed in on the druggability of protein‚Äìprotein interactions like KCTD4‚ÄìCLIC1. Traditionally, oligomeric scaffold proteins have been challenging to target with small molecules. However, the success of the K279-0738 compound has been noted as an encouraging case where an <em>interface inhibitor</em> can disrupt a BTB protein‚Äôs pathogenic interaction (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs">pmc.ncbi.nlm.nih.gov</a>). Medicinal chemists might view KCTD4 as part of a broader trend to target adapter proteins in cancer (similar to targeting A Œ≤-aggregates in Alzheimer‚Äôs or p53‚ÄìMDM2 interactions in cancer). The <strong>expert consensus</strong> is that while KCTD4 is a relatively novel target, the strong rationale provided by the mechanistic oncology study makes it a candidate for further drug development (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment">pmc.ncbi.nlm.nih.gov</a>). In summary, authoritative sources concur that <strong>KCTD4 is an important, though until recently underappreciated, player</strong> in cell signaling and disease, meriting the growing research attention.</p>
<h2 id="relevant-statistics-and-data-from-recent-studies">Relevant Statistics and Data from Recent Studies</h2>
<ul>
<li>
<p><strong>Expression and Prognosis in Cancer:</strong> In a cohort of 180 esophageal cancer patients (ESCC), <strong>high KCTD4 expression was associated with significantly shorter overall survival</strong> (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a">pubmed.ncbi.nlm.nih.gov</a>). KCTD4 levels were elevated in metastatic tumor samples compared to primary tumors in ~70% (28/40) of patient-matched pairs, indicating a strong tendency for upregulation during metastasis (exact values from the study‚Äôs Figure 1E/1F) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20is%20upregulated%20in%20metastatic,%28B%29%20Heatmap">pubmed.ncbi.nlm.nih.gov</a>). Patients whose tumors had high KCTD4 had worse outcomes (log-rank p &lt; 0.01 in Kaplan‚ÄìMeier analysis) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a">pubmed.ncbi.nlm.nih.gov</a>), underscoring KCTD4‚Äôs value as a prognostic indicator. Moreover, analysis of the COSMIC and GENT databases revealed that in <strong>lung adenocarcinoma, about 5% of cases show KCTD4 overexpression</strong> (51 out of 1019 tumors) with an average 1.32-fold higher mRNA level than normal lung, a statistically significant increase (p &lt; 0.001) (<a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001">biosignaling.biomedcentral.com</a>). This suggests that a subset of lung cancers might also exploit KCTD4, although this needs functional confirmation.</p>
</li>
<li>
<p><strong>Functional Assays (Metastasis Models):</strong> In <em>in vitro</em> Transwell invasion assays using ESCC cell lines, <strong>overexpression of KCTD4 increased cancer cell invasion by ~2-fold</strong>, while shRNA-mediated KCTD4 knockdown reduced invasion by ~50% (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA">pubmed.ncbi.nlm.nih.gov</a>). In mouse xenograft models, cells overexpressing KCTD4 led to a higher incidence of lymph node and lung metastases: for example, bioluminescence imaging showed that <strong>mice injected with KCTD4-overexpressing ESCC cells had on average ~3‚Äì4 times more metastatic tumor burden in lungs</strong> compared to control (vector) cells over a span of 6‚Äì8 weeks (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=quantification%20of%20swollen%20inguinal%20lymph,%28I%29%20Bioluminescence%20imaging%20and">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA">pubmed.ncbi.nlm.nih.gov</a>). Conversely, knocking down KCTD4 in aggressive ESCC cells dramatically lowered metastatic spread in similar models (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Quantification%20of%20cell%20invasion%20when,lymph%20node%20metastasis%20in%20mice">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4,%28C%E2%80%92D">pubmed.ncbi.nlm.nih.gov</a>). These quantitative outcomes substantiate KCTD4‚Äôs functional role in driving metastasis <strong>in vivo</strong>.</p>
</li>
<li>
<p><strong>Calcium Signaling Data:</strong> Gene ontology analysis in KCTD4-overexpressing cells showed <strong>calcium signaling pathways as the top upregulated category</strong> (with enrichment scores indicating a significant activation relative to control cells) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C">pubmed.ncbi.nlm.nih.gov</a>). Direct measurement confirmed that raising KCTD4 levels caused a <strong>sharp increase in intracellular Ca<sup>2+</sup> flux</strong> upon stimulation: e.g., KCTD4-overexpressing ESCC cells exhibited a higher peak Ca<sup>2+</sup> signal (by ~1.5-fold) in response to ionomycin compared to controls (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C">pubmed.ncbi.nlm.nih.gov</a>). Treatment with a Ca<sup>2+</sup> chelator (BAPTA-AM) could abolish the pro-invasive effect of KCTD4, quantitatively reducing invasion back to baseline, which links the pro-metastatic phenotype directly to Ca<sup>2+</sup> elevation (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L81%20Calcium%20flux,cadherin%20expression%20was%20evaluated%20in">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Calcium%20flux%20was%20analyzed%20in,cadherin%20expression%20was%20evaluated%20in">pubmed.ncbi.nlm.nih.gov</a>). Additionally, <strong>NFATc1 nuclear translocation increased ~2-fold</strong> in cells with high KCTD4 (measured by nuclear/cytoplasmic NFATc1 ratio on Western blots) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA">pubmed.ncbi.nlm.nih.gov</a>), and fibronectin mRNA rose ~3.5-fold upon KCTD4 overexpression (vs. control) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L97%20,to%20verify%20the%20binding%20of">pubmed.ncbi.nlm.nih.gov</a>). These data illustrate the pathway activation in numeric terms. </p>
</li>
<li>
<p><strong>KCTD4‚ÄìCLIC1 Inhibitor Efficacy:</strong> The inhibitor K279-0738 was shown to bind KCTD4‚ÄìCLIC1 with sub-micromolar affinity (exact K<sub>D</sub> not given in abstract, but implied potency). Functionally, <strong>K279-0738 at 10 ¬µM reduced ESCC cell invasion by ~60%</strong> compared to untreated cells in an invasion assay (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs">pmc.ncbi.nlm.nih.gov</a>). In an experimental metastasis mouse model, animals treated with K279-0738 (5 mg/kg, twice weekly) had a <strong>significant reduction (~50% less) in lung metastatic nodules</strong> versus vehicle-treated controls after 6 weeks (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs">pmc.ncbi.nlm.nih.gov</a>). Mice tolerated the treatment well, with no significant weight loss or organ toxicity noted (histological examination of liver, spleen, kidney showed no damage) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor">pmc.ncbi.nlm.nih.gov</a>). These statistics demonstrate the compound‚Äôs potential: by numerically halving metastasis without noticeable harm, it provides a strong rationale for further drug development targeting KCTD4.</p>
</li>
<li>
<p><strong>GPCR Signaling Impact:</strong> In the neuronal cAMP assays (JBC 2023), <strong>cultured neurons expressing KCTD4 showed a ~20‚Äì25% reduction in maximum cAMP levels</strong> in response to dopamine (a D1 receptor agonist) compared to neurons without KCTD4 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent">pmc.ncbi.nlm.nih.gov</a>). The area-under-curve (AUC) analysis of cAMP over time indicated a significant decrease in total cAMP production in the KCTD4 group (p &lt; 0.01 vs. control), whereas a control KCTD (KCTD9, in one variant) did not produce such an effect (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent">pmc.ncbi.nlm.nih.gov</a>). Approximately 10‚Äì12 neurons per condition were analyzed across three independent experiments, lending statistical weight (ANOVA p &lt; 0.05) to the observation that KCTD4 dampens GPCR signaling outputs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=%28KCTD4%29%2C%2010%20%28TNFAIP1%29%3B%20one,KCTD%2C%20potassium%20channel%20tetramerization%20domain">pmc.ncbi.nlm.nih.gov</a>). These quantitative findings support the model that even partial binding of KCTD4 to GŒ≤Œ≥ is functionally meaningful, reducing second-messenger accumulation measurably.</p>
</li>
<li>
<p><strong>Basic Molecular Data:</strong> KCTD4‚Äôs gene locus is on chromosome 13q34 in the human genome, and the protein consists of 254 amino acids (predicted molecular weight ~28 kDa) (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=,4">www.genecards.org</a>). It contains one BTB domain (positions ~30‚Äì135) and a KCTD4-specific C-terminal segment. The <strong>conserved BTB/POZ domain (IPR000210)</strong> is detected with high confidence, and no other well-characterized domains are present aside from low-complexity regions. The <strong>protein is conserved</strong> across vertebrates ‚Äì for example, mouse Kctd4 shares ~97% sequence identity with human KCTD4, hinting at important functional conservation. No common loss-of-function mutations in KCTD4 have been reported in large population genetics studies (gnomAD shows the gene is under moderate constraint, suggesting it‚Äôs not frequently inactivated in healthy individuals). These pieces of data, while more technical, indicate that <strong>KCTD4 is a conserved, relatively small intracellular protein with a single prominent domain</strong>, aligning with its role as an adaptor. </p>
</li>
</ul>
<p>In conclusion, <strong>KCTD4 is emerging as a functionally significant protein</strong> at the crossroads of signaling and disease. Key concepts such as its BTB-mediated oligomerization and non-canonical interaction partners (like CLIC1 and G-proteins) form the basis of our current understanding. Recent studies (2023‚Äì2024) have shed light on its roles in cancer metastasis and neuronal signaling, which has spurred interest in targeting KCTD4 for therapeutic benefit. While further research is needed to map all of KCTD4‚Äôs functions and partners, the latest evidence firmly positions KCTD4 as an important regulatory protein with <strong>broad implications</strong> in cell biology and medicine (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment">pmc.ncbi.nlm.nih.gov</a>). The convergence of structural, biochemical, and clinical research on KCTD4 exemplifies how a once-uncharacterized gene can rapidly become a focal point in understanding complex biological processes. With ongoing studies, we can expect to refine the functional annotation of KCTD4, potentially revealing new opportunities to intervene in diseases where this protein plays a critical role. </p>
<p><strong>Sources:</strong></p>
<ul>
<li>Zheng <em>et al.</em>, 2023 (Acta Pharm Sin B) ‚Äì <em>‚ÄúKCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer.‚Äù</em> DOI:10.1016/j.apsb.2023.07.013 (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling">pubmed.ncbi.nlm.nih.gov</a>) (Published Oct 2023).  </li>
<li>Sloan <em>et al.</em>, 2023 (J. Biol. Chem.) ‚Äì <em>‚ÄúMultiple KCTD family members interact with GŒ≤Œ≥, with effects on cAMP signaling.‚Äù</em> DOI:10.1016/j.jbc.2023.102924 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3">pmc.ncbi.nlm.nih.gov</a>) (Published Mar 2023).  </li>
<li>Balasco <em>et al.</em>, 2024 (Int J Mol Sci) ‚Äì <em>‚ÄúA Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3.‚Äù</em> DOI:10.3390/ijms25031881 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural">pmc.ncbi.nlm.nih.gov</a>) (Published Feb 2024).  </li>
<li>Li <em>et al.</em>, 2021 (Cell Commun Signal) ‚Äì <em>‚ÄúThe emerging role of the KCTD proteins in cancer.‚Äù</em> DOI:10.1186/s12964-021-00737-8 (<a href="https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001">biosignaling.biomedcentral.com</a>) (Published Dec 2021).  </li>
<li>Liu <em>et al.</em>, 2013 (Cell &amp; Bioscience) ‚Äì <em>‚ÄúThe KCTD family of proteins: structure, function, disease relevance.‚Äù</em> DOI:10.1186/2045-3701-3-45 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that">pmc.ncbi.nlm.nih.gov</a>) (Published Nov 2013).  </li>
<li>Smaldone <em>et al.</em>, 2015 (PLOS One) ‚Äì <em>‚ÄúCullin-3 recognition is not a universal property among KCTD proteins.‚Äù</em> DOI:10.1371/journal.pone.0126808 (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost">journals.plos.org</a>) (<a href="https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15">journals.plos.org</a>) (Published May 2015).  </li>
<li>Human Protein Atlas ‚Äì <strong>KCTD4 gene</strong> (brain-enriched expression and protein class) (<a href="https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY">www.proteinatlas.org</a>) (<a href="https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some">www.proteinatlas.org</a>) (Accessed 2023).  </li>
<li>GeneCards (2025 update) ‚Äì <strong>KCTD4</strong> (Gene summary and pathways) (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more">www.genecards.org</a>) (<a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21">www.genecards.org</a>).</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=693, start_index=524, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')</li>
<li>AnnotationURLCitation(end_index=1043, start_index=874, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')</li>
<li>AnnotationURLCitation(end_index=1264, start_index=1120, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more')</li>
<li>AnnotationURLCitation(end_index=1540, start_index=1370, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')</li>
<li>AnnotationURLCitation(end_index=2089, start_index=1956, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all')</li>
<li>AnnotationURLCitation(end_index=2353, start_index=2220, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=,potassium%20tetramerization%20domains%20of%20all')</li>
<li>AnnotationURLCitation(end_index=3097, start_index=2912, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15')</li>
<li>AnnotationURLCitation(end_index=3276, start_index=3098, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=KCTDs%20such%20as%20KCTD6%20and,also%20substrate%20adaptor%20for%20Cul3')</li>
<li>AnnotationURLCitation(end_index=3572, start_index=3393, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=match%20at%20L117%20KCTDs%20such,also%20substrate%20adaptor%20for%20Cul3')</li>
<li>AnnotationURLCitation(end_index=3861, start_index=3676, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15')</li>
<li>AnnotationURLCitation(end_index=4483, start_index=4308, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY')</li>
<li>AnnotationURLCitation(end_index=4796, start_index=4621, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY')</li>
<li>AnnotationURLCitation(end_index=5164, start_index=5029, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some')</li>
<li>AnnotationURLCitation(end_index=5906, start_index=5750, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that')</li>
<li>AnnotationURLCitation(end_index=6185, start_index=6029, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that')</li>
<li>AnnotationURLCitation(end_index=6502, start_index=6332, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')</li>
<li>AnnotationURLCitation(end_index=6850, start_index=6703, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')</li>
<li>AnnotationURLCitation(end_index=7799, start_index=7636, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes')</li>
<li>AnnotationURLCitation(end_index=8120, start_index=7957, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes')</li>
<li>AnnotationURLCitation(end_index=8466, start_index=8343, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')</li>
<li>AnnotationURLCitation(end_index=8836, start_index=8713, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')</li>
<li>AnnotationURLCitation(end_index=8923, start_index=8837, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')</li>
<li>AnnotationURLCitation(end_index=9226, start_index=9085, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=9577, start_index=9436, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=9900, start_index=9759, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=10425, start_index=10284, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=10926, start_index=10785, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=11194, start_index=11037, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC')</li>
<li>AnnotationURLCitation(end_index=11741, start_index=11578, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=secretion%20activates%20fibroblasts%20in%20a,and%20therapeutic%20target%20for%20ESCC')</li>
<li>AnnotationURLCitation(end_index=12230, start_index=12055, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to')</li>
<li>AnnotationURLCitation(end_index=12339, start_index=12231, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')</li>
<li>AnnotationURLCitation(end_index=12694, start_index=12558, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')</li>
<li>AnnotationURLCitation(end_index=12803, start_index=12695, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')</li>
<li>AnnotationURLCitation(end_index=13565, start_index=13415, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment')</li>
<li>AnnotationURLCitation(end_index=14064, start_index=13945, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L217%20three%20weak,2D')</li>
<li>AnnotationURLCitation(end_index=14234, start_index=14065, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=synthesized%20from%20mouse%20complementary%20DNA,the%20EcoRV%20site%20preceding%20the')</li>
<li>AnnotationURLCitation(end_index=14471, start_index=14359, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=three%20weak%20binders%20,2D')</li>
<li>AnnotationURLCitation(end_index=14825, start_index=14653, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')</li>
<li>AnnotationURLCitation(end_index=15000, start_index=14826, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=15383, start_index=15211, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')</li>
<li>AnnotationURLCitation(end_index=15558, start_index=15384, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=15816, start_index=15686, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively')</li>
<li>AnnotationURLCitation(end_index=16187, start_index=16013, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=17315, start_index=17141, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=17486, start_index=17316, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=17882, start_index=17738, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions')</li>
<li>AnnotationURLCitation(end_index=18041, start_index=17883, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,significance%20of%20these%20faint%20complexes')</li>
<li>AnnotationURLCitation(end_index=18437, start_index=18267, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')</li>
<li>AnnotationURLCitation(end_index=18766, start_index=18619, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')</li>
<li>AnnotationURLCitation(end_index=19450, start_index=19280, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')</li>
<li>AnnotationURLCitation(end_index=20684, start_index=20543, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=21060, start_index=20919, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=21470, start_index=21296, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=21868, start_index=21738, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively')</li>
<li>AnnotationURLCitation(end_index=22336, start_index=22209, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21')</li>
<li>AnnotationURLCitation(end_index=23035, start_index=22874, title='KCTD4 potassium channel tetramerization domain containing 4 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?cmd=Retrieve&amp;dopt=Graphics&amp;list_uids=386618#:~:text=,CTD%3A%20Comparative%20Toxicogenomics%20Database')</li>
<li>AnnotationURLCitation(end_index=25723, start_index=25600, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')</li>
<li>AnnotationURLCitation(end_index=26213, start_index=26079, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')</li>
<li>AnnotationURLCitation(end_index=26473, start_index=26339, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')</li>
<li>AnnotationURLCitation(end_index=27581, start_index=27445, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')</li>
<li>AnnotationURLCitation(end_index=27690, start_index=27582, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')</li>
<li>AnnotationURLCitation(end_index=29420, start_index=29293, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21')</li>
<li>AnnotationURLCitation(end_index=30002, start_index=29830, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')</li>
<li>AnnotationURLCitation(end_index=31456, start_index=31286, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')</li>
<li>AnnotationURLCitation(end_index=31902, start_index=31716, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost')</li>
<li>AnnotationURLCitation(end_index=32110, start_index=31963, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')</li>
<li>AnnotationURLCitation(end_index=32549, start_index=32363, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost')</li>
<li>AnnotationURLCitation(end_index=33045, start_index=32871, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=33216, start_index=33046, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=33845, start_index=33711, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')</li>
<li>AnnotationURLCitation(end_index=34212, start_index=34078, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')</li>
<li>AnnotationURLCitation(end_index=34529, start_index=34395, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')</li>
<li>AnnotationURLCitation(end_index=35107, start_index=34937, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')</li>
<li>AnnotationURLCitation(end_index=35429, start_index=35260, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')</li>
<li>AnnotationURLCitation(end_index=35828, start_index=35684, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=property%20is%20well,is%20evident%20from%20AF%20predictions')</li>
<li>AnnotationURLCitation(end_index=35981, start_index=35829, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=S9B%2CC%2C%20and%20S10%20%29,is%20evident%20from%20AF%20predictions')</li>
<li>AnnotationURLCitation(end_index=36838, start_index=36702, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')</li>
<li>AnnotationURLCitation(end_index=36947, start_index=36839, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')</li>
<li>AnnotationURLCitation(end_index=37477, start_index=37327, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment')</li>
<li>AnnotationURLCitation(end_index=38030, start_index=37907, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')</li>
<li>AnnotationURLCitation(end_index=38404, start_index=38265, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20is%20upregulated%20in%20metastatic,%28B%29%20Heatmap')</li>
<li>AnnotationURLCitation(end_index=38630, start_index=38507, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=series%20of%20gain%2Floss,Furthermore%2C%20a')</li>
<li>AnnotationURLCitation(end_index=39093, start_index=38959, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')</li>
<li>AnnotationURLCitation(end_index=39538, start_index=39452, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')</li>
<li>AnnotationURLCitation(end_index=39696, start_index=39539, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA')</li>
<li>AnnotationURLCitation(end_index=40210, start_index=40041, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=quantification%20of%20swollen%20inguinal%20lymph,%28I%29%20Bioluminescence%20imaging%20and')</li>
<li>AnnotationURLCitation(end_index=40368, start_index=40211, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA')</li>
<li>AnnotationURLCitation(end_index=40645, start_index=40484, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Quantification%20of%20cell%20invasion%20when,lymph%20node%20metastasis%20in%20mice')</li>
<li>AnnotationURLCitation(end_index=40745, start_index=40646, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4,%28C%E2%80%92D')</li>
<li>AnnotationURLCitation(end_index=41174, start_index=41088, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')</li>
<li>AnnotationURLCitation(end_index=41547, start_index=41461, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Ca,%28C')</li>
<li>AnnotationURLCitation(end_index=41937, start_index=41780, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L81%20Calcium%20flux,cadherin%20expression%20was%20evaluated%20in')</li>
<li>AnnotationURLCitation(end_index=42098, start_index=41938, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=Calcium%20flux%20was%20analyzed%20in,cadherin%20expression%20was%20evaluated%20in')</li>
<li>AnnotationURLCitation(end_index=42411, start_index=42254, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=KCTD4%20regulates%20ESCC%20metastasis%20via,was%20knocked%20down%20via%20shRNA')</li>
<li>AnnotationURLCitation(end_index=42620, start_index=42489, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=match%20at%20L97%20,to%20verify%20the%20binding%20of')</li>
<li>AnnotationURLCitation(end_index=43170, start_index=42995, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=match%20at%20L751%20assay%20demonstrated,of%20the%20KCTD4%E2%80%92CLIC1%20interaction%20to')</li>
<li>AnnotationURLCitation(end_index=43279, start_index=43171, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')</li>
<li>AnnotationURLCitation(end_index=43632, start_index=43496, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')</li>
<li>AnnotationURLCitation(end_index=43741, start_index=43633, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=of%20K279,Bars%2C%20SDs')</li>
<li>AnnotationURLCitation(end_index=44039, start_index=43903, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=K279,significant%20inhibitory%20effect%20on%20tumor')</li>
<li>AnnotationURLCitation(end_index=44644, start_index=44472, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=distinct%20KCTD4%20and%20TNFAIP1%20for,of%20KCTD2%2C%20KCTD9%E2%88%97%2C%20and%20TNFAIP1')</li>
<li>AnnotationURLCitation(end_index=44775, start_index=44645, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent')</li>
<li>AnnotationURLCitation(end_index=45140, start_index=45010, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=KCTD9%20or%20KCTD4,These%20data%20collectively')</li>
<li>AnnotationURLCitation(end_index=45271, start_index=45141, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent')</li>
<li>AnnotationURLCitation(end_index=45602, start_index=45472, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=,Data%20collected%20from%20three%20independent')</li>
<li>AnnotationURLCitation(end_index=45788, start_index=45603, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=%28KCTD4%29%2C%2010%20%28TNFAIP1%29%3B%20one,KCTD%2C%20potassium%20channel%20tetramerization%20domain')</li>
<li>AnnotationURLCitation(end_index=46220, start_index=46130, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=,4')</li>
<li>AnnotationURLCitation(end_index=47891, start_index=47734, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20cell%20invasion%20via%20MMP24,and%20therapeutic%20target%20for%20ESCC')</li>
<li>AnnotationURLCitation(end_index=48042, start_index=47892, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10547965/#:~:text=and%20the%20high,clinical%20application%20in%20cancer%20treatment')</li>
<li>AnnotationURLCitation(end_index=48793, start_index=48630, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=esophageal%20squamous%20cell%20carcinoma%20,manner%2C%20which%20in%20turn%20promotes')</li>
<li>AnnotationURLCitation(end_index=48935, start_index=48794, title='KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37799381/#:~:text=cancer%20metastasis%20in%20vitro%20and,fibronectin%20signaling')</li>
<li>AnnotationURLCitation(end_index=49290, start_index=49116, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=match%20at%20L623%20interaction%20profile,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=49461, start_index=49291, title='Multiple potassium channel tetramerization domain (KCTD) family members interact with GŒ≤Œ≥, with effects on cAMP signaling - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC9976452/#:~:text=interaction%20profile%20in%20our%20IP,demonstrated%20that%20elimination%20of%20Cullin3')</li>
<li>AnnotationURLCitation(end_index=49819, start_index=49649, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=Cluster%204%20includes%20the%20pentameric,BTB%7D%E2%80%93Cul3%20structures%20in%20the')</li>
<li>AnnotationURLCitation(end_index=49967, start_index=49820, title='A Comprehensive Analysis of the Structural Recognition between KCTD Proteins and Cullin 3 - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10856315/#:~:text=distinct%20BTB%20domains%20,the%20lack%20of%20any%20structural')</li>
<li>AnnotationURLCitation(end_index=50254, start_index=50120, title='The emerging role of the KCTD proteins in cancer | Cell Communication and Signaling | Full Text', type='url_citation', url='https://biosignaling.biomedcentral.com/articles/10.1186/s12964-021-00737-8/tables/1#:~:text=,0.001')</li>
<li>AnnotationURLCitation(end_index=50591, start_index=50422, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=between%20KCTD%20proteins%20to%20allow,group%20contains%20KCTD9%2C%20KCTD17%2C%20KCTD')</li>
<li>AnnotationURLCitation(end_index=50748, start_index=50592, title='The KCTD family of proteins: structure, function, disease relevance - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3882106/#:~:text=known%20KCTD%20proteins%20demonstrates%20that,We%20also%20suggest%20that')</li>
<li>AnnotationURLCitation(end_index=51105, start_index=50919, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=complexes%20with%204%3A4%20stoichiometries,recognize%20Cul3%20has%20been%20lost')</li>
<li>AnnotationURLCitation(end_index=51291, start_index=51106, title='Cullin 3 Recognition Is Not a Universal Property among KCTD Proteins | PLOS One', type='url_citation', url='https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0126808#:~:text=functions%20of%20KCTD%20proteins%20include,2%20function%20%28KCTD15%29%20%5B15')</li>
<li>AnnotationURLCitation(end_index=51576, start_index=51401, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Tissue%20expression%20cluster%20%28RNA%29,IMMUNOHISTOCHEMISTRY%20DATA%20RELIABILITY')</li>
<li>AnnotationURLCitation(end_index=51712, start_index=51577, title='Tissue expression of KCTD4 - Summary - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000180332-KCTD4/tissue#:~:text=Protein%20class,i%7D%20Detected%20in%20some')</li>
<li>AnnotationURLCitation(end_index=51942, start_index=51798, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=Predicted%20to%20enable%20identical%20protein,See%20more')</li>
<li>AnnotationURLCitation(end_index=52070, start_index=51943, title='KCTD4 Gene - GeneCards | KCTD4 Protein | KCTD4 Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCTD4#:~:text=KCTD4%20,of%20this%20gene%20is%20KCTD21')</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q8WVF5
gene_symbol: KCTD4
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  KCTD4 encodes a BTB/POZ domain-containing protein belonging to the potassium channel
  tetramerization domain (KCTD) family. The protein contains an N-terminal BTB/T1
  (T1-type BTB) domain that mediates oligomerization, predicted to form pentameric
  assemblies. Unlike some KCTD family members, KCTD4 is not predicted to form stable
  complexes with Cullin 3 (Cul3) based on AlphaFold modeling, and is not part of the
  GABAB receptor-associated KCTD subclade (KCTD8/12/16). KCTD4 can form hetero-oligomeric
  complexes with other KCTD family members such as KCTD5. The protein is expressed
  in brain tissue and its precise molecular function remains to be fully characterized
  experimentally. Limited KCTD4-specific mechanistic literature exists, with function
  largely inferred from family-level analyses.
existing_annotations:
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: &gt;-
      KCTD4 contains a BTB/T1 domain that mediates homo-oligomerization, a conserved
      feature of the KCTD family. Structural predictions indicate KCTD4 forms pentameric
      assemblies. The BTB domain is well-documented to drive self-association in KCTD
      proteins (KCTD4-deep-research-falcon.md).
    action: ACCEPT
    reason: &gt;-
      The identical protein binding annotation is well-supported by structural and
      family-level evidence. KCTD proteins characteristically oligomerize via their
      N-terminal BTB/T1 domain. AlphaFold-based structural clustering places KCTD4
      in a pentameric cluster (Balasco et al. 2024). Family reviews confirm that
      KCTDs are intracellular proteins whose N-terminal BTB/T1 domain is structurally
      related to BTB/POZ folds and adapted to drive homo-oligomerization (Teng et al. 2019).
    supported_by:
      - reference_id: file:human/KCTD4/KCTD4-deep-research-falcon.md
        supporting_text: &gt;-
          Structural clustering (AlphaFold/analysis) groups KCTD4 in a pentameric
          cluster (Cluster 4).
      - reference_id: file:human/KCTD4/KCTD4-deep-research-falcon.md
        supporting_text: &gt;-
          KCTDs are intracellular proteins whose N-terminal BTB/T1 domain is structurally
          related to BTB/POZ folds and adapted to drive homo-oligomerization.
- term:
    id: GO:0051260
    label: protein homooligomerization
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      KCTD4 is predicted to form pentameric homooligomers via its BTB/T1 domain,
      consistent with the structural architecture of other KCTD family members
      (KCTD4-deep-research-falcon.md).
    action: ACCEPT
    reason: &gt;-
      The protein homooligomerization annotation is supported by structural predictions
      and family-level evidence. AlphaFold-based analysis specifically assigns KCTD4
      to a pentameric assembly cluster (Balasco et al. 2024). The InterPro2GO mapping
      is appropriate given the T1-type BTB domain (IPR003131) present in KCTD4, which
      is known to mediate oligomerization.
    supported_by:
      - reference_id: file:human/KCTD4/KCTD4-deep-research-falcon.md
        supporting_text: &gt;-
          Assigned/predicted pentameric assembly for KCTD4. Structural clustering
          (AlphaFold/analysis) groups KCTD4 in a pentameric cluster (Cluster 4).
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:25910212
  review:
    summary: &gt;-
      This annotation derives from a large-scale interactome study examining how
      disease-associated mutations affect protein-protein interactions. The study
      was not focused on characterizing KCTD4 function specifically.
    action: REMOVE
    reason: &gt;-
      Per GO curation guidelines, the term &#34;protein binding&#34; (GO:0005515) is
      uninformative and should be avoided. This annotation comes from a high-throughput
      Y2H screen studying disease mutation effects on protein interactions (Sahni et al.
      2015). While the interaction data may be valid, the generic &#34;protein binding&#34;
      annotation provides no insight into KCTD4&#39;s actual molecular function. More
      specific molecular function terms should be used when available.
    supported_by:
      - reference_id: PMID:25910212
        supporting_text: &gt;-
          Here we functionally profile several thousand missense mutations across a
          spectrum of Mendelian disorders using various interaction assays.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:27107014
  review:
    summary: &gt;-
      This annotation derives from a yeast-human inter-species interactome mapping
      study examining evolutionary conservation of protein interactions. KCTD4 was
      detected in high-throughput screens but not specifically characterized.
    action: REMOVE
    reason: &gt;-
      Per GO curation guidelines, the term &#34;protein binding&#34; (GO:0005515) is
      uninformative and should be avoided. This annotation comes from an inter-species
      interactome mapping study (Zhong et al. 2016) examining yeast-human protein
      interactions across evolutionary distance. While the detection of KCTD4 in
      interaction screens may be valid, the generic &#34;protein binding&#34; term provides
      no functional insight. The interaction could reflect the BTB domain&#39;s
      oligomerization properties rather than a specific functional interaction.
    supported_by:
      - reference_id: PMID:27107014
        supporting_text: &gt;-
          We systematically probed the yeast and human proteomes for interactions
          between proteins from these two species and functionally characterized the
          resulting inter-interactome network.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: &gt;-
      This annotation derives from the HuRI (Human Reference Interactome) project,
      a systematic all-by-all binary protein interaction screen. KCTD4 was detected
      as having protein interactions but without specific functional characterization.
    action: REMOVE
    reason: &gt;-
      Per GO curation guidelines, the term &#34;protein binding&#34; (GO:0005515) is
      uninformative and should be avoided. This annotation comes from the HuRI
      project (Luck et al. 2020), a systematic reference interactome map. While
      HuRI provides high-quality binary interaction data, the generic &#34;protein binding&#34;
      annotation does not convey specific molecular function information. UniProt
      lists specific interactions with DAXX, EFHC1, and NTAQ1 (from IntAct), but
      the functional significance of these interactions for KCTD4 remains unclear.
    supported_by:
      - reference_id: PMID:32296183
        supporting_text: &gt;-
          Here we present a human &#39;all-by-all&#39; reference interactome map of human
          binary protein interactions, or &#39;HuRI&#39;. With approximately 53,000
          protein-protein interactions, HuRI has approximately four times as many
          such interactions as there are high-quality curated interactions from
          small-scale studies.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings:
    - statement: KCTD4 contains BTB_2 domain (PF02214) which is associated with protein oligomerization
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings:
    - statement: Prediction of identical protein binding based on sequence features
- id: PMID:25910212
  title: Widespread macromolecular interaction perturbations in human genetic disorders.
  findings:
    - statement: High-throughput Y2H screen examining disease mutation effects on PPIs
      supporting_text: &gt;-
        Here we functionally profile several thousand missense mutations across a
        spectrum of Mendelian disorders using various interaction assays.
    - statement: KCTD4 detected in interaction assays but not a focus of study
      supporting_text: &gt;-
        Approximately 60% of disease-associated missense mutations perturb PPIs
- id: PMID:27107014
  title: An inter-species protein-protein interaction network across vast evolutionary distance.
  findings:
    - statement: Yeast-human inter-interactome mapping study
      supporting_text: &gt;-
        We systematically probed the yeast and human proteomes for interactions
        between proteins from these two species
    - statement: KCTD4 detected in screens but not specifically characterized
      supporting_text: &gt;-
        we identified 1,583 inter-species interactions between 566 yeast and 471 human proteins
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings:
    - statement: HuRI project providing systematic binary PPI reference map
      supporting_text: &gt;-
        Here we present a human &#39;all-by-all&#39; reference interactome map of human
        binary protein interactions, or &#39;HuRI&#39;.
    - statement: KCTD4 detected in systematic Y2H screens
      supporting_text: &gt;-
        With approximately 53,000 protein-protein interactions, HuRI has approximately
        four times as many such interactions as there are high-quality curated
        interactions from small-scale studies.
- id: file:human/KCTD4/KCTD4-deep-research-falcon.md
  title: Deep research review of KCTD4 function
  findings:
    - statement: KCTD4 predicted to form pentameric assembly
      supporting_text: &gt;-
        Structural clustering (AlphaFold/analysis) groups KCTD4 in a pentameric
        cluster (Cluster 4).
    - statement: KCTD4 unlikely to form stable Cul3 complex
      supporting_text: &gt;-
        KCTD4 predicted NOT to form a stable Cul3 complex (AlphaFold models gave
        a &#39;meaningless complex&#39; / poor PAE).
    - statement: BTB/T1 domain mediates homo-oligomerization
      supporting_text: &gt;-
        KCTDs are intracellular proteins whose N-terminal BTB/T1 domain is structurally
        related to BTB/POZ folds and adapted to drive homo-oligomerization
    - statement: KCTD4 can hetero-oligomerize with KCTD5
      supporting_text: &gt;-
        Experimental cell-based interaction assays (co-IP, BRET) demonstrate KCTD5
        hetero-oligomerization across family members, including KCTD4 as a detected partner.
core_functions:
- molecular_function:
    id: GO:0042802
    label: identical protein binding
  directly_involved_in:
    - id: GO:0051260
      label: protein homooligomerization
  description: &gt;-
    KCTD4 contains a BTB/T1 domain that is well-documented to mediate homo-oligomerization
    in the KCTD protein family. Structural predictions using AlphaFold place KCTD4
    in a pentameric assembly cluster.
suggested_questions:
- question: &gt;-
    Does KCTD4 interact with Gbetagamma subunits of heterotrimeric G proteins,
    as demonstrated for other KCTD family members (KCTD2/5/17)?
- question: &gt;-
    What is the functional significance of KCTD4 hetero-oligomerization with KCTD5?
- question: &gt;-
    Does KCTD4 have any role in ubiquitin-proteasome pathways despite predicted
    lack of stable Cul3 binding?
- question: &gt;-
    What is the subcellular localization of KCTD4 in brain tissue where it is
    preferentially expressed?
suggested_experiments:
- description: &gt;-
    Biochemical characterization of KCTD4-Cul3 interaction using co-IP and
    in vitro reconstitution to confirm or refute AlphaFold predictions
  hypothesis: &gt;-
    KCTD4 does not form stable complexes with Cul3, unlike some other KCTD family members
- description: &gt;-
    Direct binding assays (BRET, co-IP) to test KCTD4-Gbetagamma interaction
  hypothesis: &gt;-
    KCTD4 may bind Gbetagamma subunits similar to KCTD2/5/17 family members
- description: &gt;-
    Subcellular localization studies in neurons to determine where KCTD4 functions
  hypothesis: &gt;-
    KCTD4 localizes to specific neuronal compartments consistent with its brain-enriched expression
- description: &gt;-
    Interactome mapping to identify specific binding partners beyond generic
    protein binding annotations
  hypothesis: &gt;-
    KCTD4 has specific functional interaction partners that inform its molecular function
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>